Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 7, 1990 - Issue 3
Submit an article Journal homepage
9
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 425-444 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: a flow cytometric study. ABEL, G., SZOLLOSI. J CHIHARA, G., and FACHET, J., In:. J. Immunopharmacol., 1989, 11, (6), 615–621.
  • Synthesis and phase behaviour of some novel quaternary ammonium ion derivatives of cholesterol. ABID, S. K., University of Strathclyde, Glasgow, UK, Dissertation, 1988, 234 pp.
  • Determination of hemagglutinin inclusion into the lecithin liposome membrane by the fluorescent anisotropy method. ADAMYAN, S. YA., AMABARTSUMYAN, T. G., MARIKYAN, G. G., and PETROSYAN, L. S., Biol. Zh. Arm., 1989, 42, (6), 579–581.
  • Induction of cytochrome P-450 in rat liver microsomes by perfluorodecalin. ADRIANov, N. V., ARCHAKOV, A. I., and TSIGLER, M., Biull. Eksp. Biol. Med., 1989, 108, (8), 164–166.
  • Potent immunomodulating activities of polyvinyladenine and (vinyladenine-alt-maleic acid) copolymer. AICASHI, M., IWASAKI, H., MIYAUCHI, N., SATO, T., SUNAMOTO, J., and TAKEMOTO, K., J. Bioact. Compat. Polym., 1989, 4, (2), 124–136.
  • Polymer drugs and polymeric drugs. II. Synthesis of water dispersible microspheres having 5-fluorouracil and theophylline using a water soluble macromonomer. AKASHI, M., WADA, M., YANASE, S., and MIYAUCHI, N., J. Polym. Sci., Part C: Polym. Lett., 1989, 27, (10), 377–380.
  • Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization. AKBUGA, J., Int. J. Pharm., 1989, 53, (2), 99–106.
  • Adsorption of aluminium to phosphatidylcholine vesicles. AICESON, M. A., MUNNS, D. N., and BURAU, R. G., Biochim. Biophys. Acta., 1989, 986, (1), 33–40.
  • Phase transition in surface-charged vesicular membranes. Ammov, V. N., and VLADIMIROV, Y. A., Biol. Membr., 1989, 6, (7), 765–772.
  • Effect of storage on tabletted microencapsulated aspirin granules. AL-GOHARY, 0. M., AL-GAMAL, S. S., HAMMAD, A., and MOLOKIIIA, A. M., Int. J. Pharm., 1989, 55, (I), 47–52.
  • Poly (cholesteryl methacrylate) containing liposomes. ALAMELU, S., and RAO, K. P., Makromol. Chem., Rapid Commun., 1989, 10, (11), 607–611.
  • Acceleration of cheese ripening with liposomes-entrapped proteinase: influence of liposom es net charge. ALKHALAF, W., EL-SODA, M., GRIPON, J. C., and VASSAL, L., J. Dairy Sci., 1989, 72, (9), 2233–2238.
  • Echinocytosis and microvesiculation of human erythrocytes induced by insertion of merocyanine 540 into the outer membrane leaflet. ALLAN, D., HAGELBERG, C., KALLEN, K. J., and HAEST, C. W., Biochim. Biophys. Acta., 1989, 986, (1), 115–122.
  • Recent advances in sustained release of antineoplastic drugs using liposomes which avoid uptake into the reticuloendothelial system. ALLEN, T. M., and MEHRA, T., Proc. West. Pharmacol. Soc., 1989, 32, 111–114.
  • A change in the fluidity of phosphatidylcholine liposome membrane at various concentrations of sodium deoxycholate. AMBARTSUMYAN, T. G., MARIKYAN, G. G., ADAMYAN, S. YA., PETROSYAN, L. S., and SIMONYAN, L. K. H., Biol. Membr., 1989, 6, (4), 386–389.
  • Circular dichroism of macro-ring gramicidin S analogs in the presence of liposomes. ANDO, S., TOKUNAGP N., NISHIKAWA, H., TAKIGUCHI, H., and lzumivA, N., Fukuoka Daigaku Rigaku Shuho, 1989, 19, (1), 19–23.
  • Immobilized fluorogenic substrates for proteinases: A method for visualization and quantitation of elastase release from human monocytes. ANDRADE, GORDON-P., COX, M. J., BRYNES, P. J., and Wu, C. W., Cell. Mol. Biol., 1989, 35, (4), 431–440.
  • Functional reconstitution of the olfactory membrane: incorporation of the olfactory adenylate cyclase in liposomes. ANHOLT, R. R., Biochemistry, 1988, 27, (17), 6464–6468.
  • Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin. APARISI, L., RODRIGO, J. M., SERRA, M. A., DEL-01.mo, J., BISQUERT, M., and RAGA, F., Rev. Esp. Enferm. Apar. Dig., 1989, 76, (1), 25–30.
  • Injection of the cyclic AMP-dependent protein kinase II regulatory subunit into 3T3 cells using erythrocyte ghosts. APRIKYAN, A. G., ZHULEVA, L. Yu., NESTEROVA, M. V., and SEVERIN, E. S., Biokhimiya, 1989, 54, (6), 980–986.
  • Fluorescence study of the location and dynamics of alpha-tocopherol in phospholipid vesicles. ARANDA, F. J., COUTINHO, A., BERBERAN-SANTOS, M. N., PRIETO, M. J. E., and GOMEZ-FERNANDEZ, J. C., Biochim. Biophys. Acta., 1989, 985, (1), 26–32.
  • Distribution of leptospirosis among stray dogs in the Okinawa Islands, Japan: comparison of the microcapsule and microscopic agglutination tests. ARIMITSU, Y., FUKUMURA, K., and SHINGAKI, Y., Br. Vet. J., 1989, 145, (5), 473–477.
  • Central Asian cobra venom cytotoxins-induced aggregation, permeability and fusion of liposomes. ARIPOV, T. F., GASANOV, S. E., SALAKHUTDINOV, B. A., ROZENSHTEIN, I. A., and KAMAEV, F. G., Gen. Physiol. Biophys., 1989, 8, (5), 459–474.
  • Radiation attenuation effects in photosensitive coatings of microcapsules. ARNEY, J. S., DOWLER, J. A., and RUDER, D. L., J. Imaging Sci., 1989, 33, (5), 184–188.
  • Epimerization and racemization of some chiral drugs in the presence of cyclodextrin and liposomes. Aso, Y., YostiroKA, S., and TAKEDA, Y., Chem Pharm. Bull. 1989,37, (10), 2786–2789.
  • Phagocytosis by guinea pig polymorphonuclear leukocytes of liposomes stabilized with polysaccharides. ATSUTA, Y., MURAMATSU, N., and KONDO, T., Biomater., Art if. Cells., Art if. Organs, 1989, 17, (2), 125–135.
  • Liposomes as carriers for anti-inflammatory agents. AXELSSON, B., Adv. Drug. Delivery-Rev., 1989, 3, (3), 391–404.
  • Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition. BAKKER-WOUDENBERG, I. A., LOKERSE, A. F., and ROERD1NK, F. H., J. Pharmacol. Exp. Ther., 1989, 251, (1), 312–327.
  • Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro. BAKKER-WOUDENBERG, I. A. J., LOKERSE, A. F., VINK VAN DEN BERG, J. C., and ROERDINK, F. H., Eur. J. Clin. Microbiol. Infect. Dis., 1989, 8, (7), 603–609.
  • Synthetic macrophages: Antigen presentation by liposomes bearing class II major histocompatibility complex (MHC) and membrane interleukin-1 (IL-1). BAKOUCHE, 0., and LACHMAN, L. B., J. Clin. Immunol., 1989, 9, (5), 369–377.
  • Cytotoxic liposomes: membrane interleukin-1 presented in multilamellar vesicles. BAKOUCHE, 0., LACHMAN, L. B., KNOWLES, R. D., and KLEINERMAN, E. S., Lymphokine Res., 1988,7, (4), 445–456.
  • Immunospecfic targeting of cytosine arabinonucleoside-containing liposomes to the idiotype on the surface of a murine B-cell tumor in vitro and in vivo. BANKERT, R. B., YOKOTA, S., GHOSH, S. K., MAYHEW, E., and Jou, Y. H., Cancer Res., 1989, 49, (2), 301–308.
  • The topography of acetylcholinesterase dimyrostoylphosphatidylcholine liposomes. BARBER, R. F., STUHNE-SEKALEC, L., SHEK, P. N., and STANACEV, N. Z., J. Microencapsul., 1989, 6, (3), 301–310.
  • Transient cerebral ischemia anew model in the rat based on degradable starch microspheres. BARRY, D. I., PEDERSEN, E. V., BOBKIEWICZ, T., and DIEMER, N. H., Eur. J. Clin. Invest., 1989, 19, (2, Part 2), A51.
  • Phospholipids co-isolated with rat surfactant protein C account for the apparent protein-enhanced uptake of liposomes into lung granular pneumocytes. BATES, S. R., IBAuFt, P. B., and FISHER, A. B., Exp. Lung Res., 1989, 15, (5), 695–708.
  • Porphyrin biosynthesis in mice breast carcinoma from free and liposome encapsulated 5-aminolevulinic acid. BATLLE, A. M. D. C., FUKUDA, H., and PAREDES, S., MO/. Aspects Med., 1990, 11, (1-2), 105.
  • Use of kappa carrageenan microbound diet (C-MBD) as feed for Penaeus monodon larvae. BAUTISTA, M. N., MILLAMENA, 0. M., and KANAZAWA, A., Mar. Biol. (Berl), 1989, 103, (2), 169–174.
  • Interaction of the fluoroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes. BEDARD, J., and BRYAN, L. E., Antimicrob. Agents Chemother., 1989, 33, (8), 1379–1382.
  • Second antibody for improvement of antibody imaging: liposome-entrapped and free preparations in animal and human studies. BEGENT, R. H. J., CHESTER, K. A., BAGSHAWE, K. D., KEEP, P. A., SEARLE, F., BODEN, J., BARRATT, G. M., GREEN, A. J., RIGGS, S. J., and WOODROW, D. F., Clin. Exp. Immunol., 1989, 78, (2), 307–313.
  • Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. BEHR, J. P., DEMENE1X, B., LOEFFLER, J. P., and PEREZ-MUTUL, J., Proc. Natl. Acad. Sci. USA., 1989, 86, (18), 6982–6986.
  • The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. BEISIEGEL, U., WEBER, W., THREE, G., HERZ, J., and STANLEY, K. K., Nature, 1989, 341, (6238), 162–164. Experimental model for a liposomal adjuvant. BEJAN, A., Suclu, M., DOROBANTU, I., and MAICAN, A., Rev. Roum. Biochim., 1989, 26, (1), 3–7.
  • Chemical stability of N-Trifluoroacetyldoxorubicin-14-valerate (AD-32) in aqueous media and after liposome encapsulation. BEKERS, 0., BE1JNEN, J. H., STORM, G., BULT, A., and UNDERBERG, W. J. M., Int. J. Pharm., 1989, 56, (2), 103–110.
  • Interaction of erythrocyte plasma membranes with 'gel' liposomes (neutral and negatively charged). BECTSER, N. V., ANISHCHUK, M. G., BOGDANOV, A. A. JR., and TORCHILIN, V. P., Biol. Membr., 1989, 6, (9), 955–965.
  • Genetic analysis of transgenic tobacco plants obtained by liposome-mediated transformation: absence of evidence for the mutagenic effect of inserted sequences in sixty characterized transformants. BELLINI, C., GUERCHE, P., SPIELMANN, A., GOUJAUD, J., LESAINT, C., and CABOCHE, M., J. Hered., 1989, 80, (5), 361–367.
  • Microencapsulation of emulsified oil droplets by in-situ vinyl polymerization. BERG, J., SUNDBERG, D., and KRONBERG, B., J. Microencapsul., 1989, 6, (3), 327–337.
  • In vivo stability of DTPA-HSA-microspheres labeled with radiolanthanides. BEYER, G. J., BEYER, R., BERGMANN, R., BAUER, R., HOYER, D., and SCHUBERT, H., NucCompact., 1989, 20, (2), 54–56. Dietary fat and menstrual-cycle effects on the erythrocyte ghost insulin receptor in premenopausal women. BHATHENA, S. J., BERLIN, E., Junn, J. T., JONES, J., KENNEDY, B. W., SMITH, P. M., JoNEs, D. Y., TAYLOR, P. R., and CAMPBELL, W. S., et al. Am. J. Clin. Nutr., 1989, 50, (3), 460–464.
  • Vasodilatory effect of nicotinamide on the fluidity of erythrocyte membrane and liposomes. BHATTACHARYYA, M., and NANDY, P., J. Surf. Sci. Technol., 1989, 5, (1), 13–20.
  • Monocarboxylate and alpha-ketoglutarate carriers from bovine heart mitochondria. Purification by affinity chromatography on immobilized 2-cyano-4-hydroxycinnamate. Bow, R., NALCECZ, K. A., and Azzi, A., J. Biol. Chem., 1989, 264, (30), 18024–18030.
  • Amino resin microcapsules. III. Release properties. BONATZ, E., DIETRICH, K., HERMA, H., NASTE, R., WALTER, M., and TEIGE, W., Acta Polym., 1989, 40, (11), 683–690.
  • Micro- and nanoparticles as drug carrier systems, especially with respect to methods of preparation. BORNSCHEIN, M., MELAGARI, P., BISMARCK, C., and KEIPERT, S., Pharmazie, 1989, 44, (9), 585–593.
  • Effects of oral administration of artificial cells. Immobilized phenylalanine ammonia-lyase on intestinal amino acids of phenylketonuric rats. BOURGET, L., and CHANG, T. M. S., Biomater., Artif. Cells, Artif. Organs, 1989, 17, (2), 161–181.
  • Transport measurement of anions, nonelectrolytes,, and water in red blood cell and ghost systems. BRAFIM, J., Methods Enzymol., 1989, 173, 160–175.
  • Hemoglobin-liposomes as blood replacement fluid. BRANDL, M., BECKER, D., and BAUER, K. H., Drug Dev. Ind. Phar., 1989, 15, (5), 655–670.
  • Liposomal encapsulation: making old and new drugs do new tricks. BRENNER, D. E., J. Natl. Cancer Inst.,1989, 81, (19), 1436–1438.
  • A 10-KD barley basic protein transfers phosphatidylcholine from liposomes to mitochondria. BREU, V., GUERBETTE, F., KADER, J. C., KANNANGARA, C. G., SVENSSON, B., and VON-WETTSTEIN-KNOWLES, P., Carlsberg Res. Commun., 1989, 54, (2), 81–84.
  • In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. BRIGHAM, K. L., MEYRICK, CHRISTMAN, B., MAGNUSON, M., KING, G., and BERRY, L. C. JR., Am. J. Med. Sci., 1989, 298, (4), 278–281.
  • A gamma camera method to monitor the use of degradable starch microspheres in hepatic arterial chemotherapy. BRITTEN, A., FLOWERDEW, A., HUNT, T., TAYLOR, I., ACKERY, D., and FLEMING, J., Eur. J. Nucl. Med., 1989, 15, (10), 649–654.
  • Removal of digoxin from the circulation using immobilized monoclonal antibodies. BRIZGYS, M. V., PINCUS, S., SIEBERT, C. J., and ROLLINS, E., J. Pharm. Sci., 1989, 78, (5), 393–398.
  • Effect of capsule permeability on growth of CHO cells in eudragit RL microcapsules: use of FITC-dextran as a marker of capsule quality. BROUGHTON, R. L., and SEFTON, M. V., Biomaterials, 1989, 10, (7), 462–465.
  • Hepatocytes immobilized by microencapsulation in artificial cells: effects on hyperbilirubinemia in Gunn rats. BRUNI, S., and CHANG, T. M. S., Biomater. Artif. . Cells Artif. Organs, 1989, 17, (4), 403–412.
  • The potentials for immunization against influenza using liposome-incorporated viral surface antigens. BURDUCEA, 0., MARCHECS, F., DUCTU, C., GRANCEA, C., NICOLAU, A., and PAUN, C., Virologie, 1989, 40, (2), 97–106.
  • Secondary structure changes of diphtheria toxin interacting with asolectin liposomes: an IR spectroscopy study. CABIAUX, V., GOORMAGHTIGH, E., WATTIEZ, R., FALMAGNE, P., and RUYSSCHAERT, J. M., Biochimie, 1989, 71, (1), 153–158.
  • The influence of polyunsaturated fatty acids on spermine inhibition of lipoperoxidation studies on liposomes prepared with microsomal and mitochondrial phospholipids of sea bass (Dicentrarchus labraa I.) and rat liver. CABRINI, L., TABOLINI, B., LAND, L., FIORENTINI, D., and SECHI, A. M., Comp. Biochem. Physiol. B, Comp. Biochem., 1989, 93, (3), 647–652.
  • Optimization of the preparation method of polyhydroxypropylmethacrylate nanoparticles. CADIEUX, C., and LENAERTS, V., Acta. Pharm. Technol., 1989, 35, (3), 160–162.
  • Development and evaluation of a system of microencapsulation of primary rat hepatocytes. CAI, Z. H., SRI, Z. Q., SHERMAN, M., and SUN, A. M., Hepatology, 1989, 10, (5), 855–860.
  • Xenotransplantation of algin-polyamino acidic microencapsulated porcine Islets of Langerhans into diabetic rodents. CALAFIORE, R., CALCINARO, F., BASTA, G., PIETROPAOLO, M., FALORINI, A. JR., MONACELLI, I. G., and BRUNETTI, P., Eta% J. Clin. Invest., 1989, 19, (2, Part 2), A14.
  • Encapsulation of the u.v.-DNA repair enzyme T-4 endonuclease V in liposomes and delivery to human cells. CECCOLI, J., ROSALES, N., Tsnms, J., and YAROSH, D. B., J. Invest. Dermatol., 1989, 93, (2), 190–194.
  • Acrylate polymers in controlled-release drug formulations. CHALABALA, M., and RAK, J., Pharmazie, 1989, 44, (7), 501–502.
  • Oximetry in cells and tissues using a nitroxide-liposome system. CHAN. H. C., GLOCKNER, J. F., and SWARTZ, H. M., Biochim. Biophys. Acta, 1989, 1014, (2), 141–144.
  • Artificial cells in medical applications with emphasis on hemoperfusion in aluminium removal and cross-over control clinical trial of reduced time hemoperfusion-hemodialysis. CHANG, T. M. S., BARRE, P., LISTER. C., and KURUVILLA, S., In Contributions to Nephrology, Biotechnology in Renal Replacement Therapy, BONOMINI, V., et a/. (eds.). (S. Karger AG: Basel, Switzerland) 1989, Vol. 70, pp. 237–249.
  • Transition of cardiolipin liposome from bilayer to hexagonal phase induced by proton. CHENG-BOUI, JIANG-GUISEN, FENG-YUANYI, ZHANG-FENGLI, and LIN-KECHUN., Ziran Zazhi, 1989, 12, (6), 477.
  • Treatment of wastewater containing metal ion with microcapsules. CHENG-YALING, CHANG-HEZHE, and YAN-ZHONG. Mo Kexue. Yu Jishu, 1988, 8, (4), 24–29.
  • Dentifrice containing microencapsulated oxygen. US Patent-4867988; September 19, 1989. CHERNACK, M. P., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1106, (3), 1917.
  • Structural alterations of human erythrocyte membranes during the interaction with positively charged liposomes. CHERNYSHOV, V. I., STEKHOVA, T. R., TARAKOVSKII, Yu. S., and BOROVYAGIN, V. L., Biol. Membr., 1989, 6, (5), 516–529.
  • Doxorubicin-loaded nanoparticles increased efficiency in murine hepatic metastases. CHIANNILKULCHAI, N., DRIOUICH, Z., BENOIT, J. P., PARODI, A. L., and COUVFtEUR, P., Se. Cancer Ther., 1989, 5, (1), 1–12.
  • 100-KDa polypeptides in peripheral clathrin-coated vesicles are required for receptor-mediated endocytosis. CHIN, D. J., STRAUBINGER, R. M., ACTON, S., NATHKE, I., and BRODSKY, F. M., Proc. Natl. Acad. Sci, USA., 1989, 86, (23), 9289–9293.
  • Blocking of lymphokine activated killer (LAK) cell mediated cytotoxicity by cell-sized beads bearing tumor cell proteins. CtioNo, A. S., HERSH, E. M., and GRIMES, W. J., J. Immunol., 1988, 141, (12), 4418–4424.
  • Activation of the complement system by liposomes. CHONN, A., Cutils, P. R., and DEVINE, D. V., Complement Inflammation, 1989, 6, (5), 322–323.
  • A comparative evaluation of the permeability of ethyl cellulose microcapsules prepared by coacervation methods. CHOWDARY, K. P. R., and ANNAPURNA, A., Indian J. Pharm. Sci., 1989, 51, (2), 53–56.
  • Method for preserving liposomes. US Patent-4857319; August 15, 1989. CROWE, J. H., and CROWE, L. M., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1105, (3), 1790–1791.
  • Generating and loading of liposomal systems for drug-delivery applications. Cum.'s, P. R., MAYER, L. D., BALLY, M. B., MADDEN, T. D., and HOPEE, M. J., Adv. Drug Delivery Rev., 1989,3, (3), 267–282.
  • Lipsome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice. CYNAMON, M. H., SWENSON, C. E., PALMER, G. S., and GINSBERG, R. S., Antzmicrob. Agents Chemother., 1989, 33, (8), 1179–1183.
  • Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors. DAL-MONTE, P., and SZOICA, F. C. JR., J. Immunol., 1989, 142, (5), 1437–1443.
  • Antigen presentation by B cells and macrophages of cytochrome c and its antigenic fragment when conjugated to the surface of liposomes. DAL-MONTE, P. R., and SZOKA, F. C. JR., Vaccine, 1989, 7, (5), 401–408.
  • Inhibition of phytohemagglutinine-induced T lymphocyte proliferation by 6-(octa-decyldithio)purine, a novel liposomal prodrug of 6-mercaptopurine. DANIEL, P. T., HOLZSCHUH, J., MULLER, C. E., ROTH, H. J., and BERG, P. A., Arch. Toxicol. Suppl. 1989, 13,179–182.
  • Liposomes in cancer therapy. DAUOUD, S. S., HUME, L. R., and JULIANO, R. L., Adv. Drug Delivery Rev., 1989, 3, (3), 405–418.
  • Comparative study of microencapsulated rat islets implanted in different diabetic models in mice. DARQUY, S., CHICHEPORTICHE, D., CAPRON, F., BOITARD, C., ROUCHETTE, J., and REACH, G., Diabetologia, 1989, 32, (7), 479A.
  • Primary immune response to liposomal tetanus tozoid in mice: the effect of mediators. DAVIS, D., and GREGORIADIS, G., Immunology, 1989, 68, (2), 277–282.
  • Preparation and characterization of lactic glycolic acid polymers and copolymers. DEASY, P. B., FINAN, M. P., and MEEGAN, M. J., J. Microencapsul., 6, (3), 369–378.
  • Dry stabilized microemulsified omega-three acid-containing oils. US Patent-4867986; September 19, 1989. DESAI, M., and MOLINARO, F., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1106, (3), 1917.
  • Cholesterol metabolism by purified cytochrome P-450scc is highly stimulated by octyl glucoside and stearic acid exclusively in large unilamellar phospholipid vesicles. DHARIWAL, M. S., and JEFCOATE, C. R., Biochemistry, 1989, 28, (21), 8397–8402.
  • Distribution of poly-hexy1-2-cyano-(3-14C)acrylate nanoparticles in healthy and chronically inflamed rabbit eyes. DIEPOLD, R., KREUTER, J., GUGGENBUHL, P., and ROBINSON, J. R., Int. J. Pharm., 1989, 54, (2), 149–153.
  • Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A. DIJKSTRA, J., MELLORS, J. W., and RYAN, J. L., Infect. Immun., 1989, 57, (11), 3357–3363.
  • A procedure for the efficient incorporation of wild-type fipopolysaccharide into liposomes for use in immunological studies. DIJKSTRA, J., RYAN, J. L., and SzoicA, F. C., J. Immunol. Methods, 1988, 114, (1-2), 197–205.
  • Scavenging effect of EDTA-fluorocarbon microspheres on lead-210. DING, X. C., LIU, C. F., Doxo, J. W., Du, J., WANG, Y. C., and HUANG, X., Acta Pharmacol. Sin., 1989, 10, (5), 473–475. Synthetic erythrocytes. DjouDIEvIcii, L., and IVANKOVICH, A. D., Grit. Rev. Ther. Drug Carrier Syst., 1989, 6, (2), 131–162.
  • Platelet distribution in rabbits following infusion of liposomes. DOERSCHUK, C. M., GIE, R. P., BALLY, M. B., CuLLis, P. R., and REINISH, L. W., Thromb. Haemost., 1989, 61, (3), 392–396.
  • Application of iodine-containing liposomes for lymphography of the mediastinum. DRAGUN, G. N., ZELENTSOV, E. L., ZORIN, Yu. A., ROZENBERG, 0. A., ZOLATAREV, K. V., and KULIPANOV, G. N., Nucl. Instrum. Methods Phys. Res. Sect. A, 1989, A282, (2–3) 495–496.
  • Protein separation via polyelectrolyte coacervation. Minix, P. L., STREGE, M. A., WEST, J., and FLINTA, C. D., Abstr. Pap. Am. Chem. Soc., 1989, 198, 5.
  • Fusion of liposomes containing a novel cationic lipid, N-(2, 3-(dioleyloxy)propy1)-N,N,N-trimethylammonium: induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles. DUZGUNES, N., GOLDSTEIN, J. A., FRIEND, D. S., and FELGNER, P. L., Biochemistry, 1989, 28, (23), 9179–2184.
  • Biophysical aspects of lipid interaction with mineral liposome model studies. EANES, E. D., Anat. Rec., 1989, 224, (2), 220–225.
  • Liposome technology in biomineralization research. EANES, E. D., and HEYWOOD, B. R. R., In New Biotechnology in Oral Research, H. M. MYERS (ed) (S. Karger AG: Basel, Switzerland) 1989, pp. 54–75.
  • Mass transfer effects in microencapsulated hybridoma cells producing monoclonal antibodies. EDMUNDS, W. W., KARGI, F., and SORENSON, C., Appl. Biochem. Biotechnol., 1989, 20–21. 603–620.
  • Chemoprophylaxis of schistosomiasis using liposome-encapsulated tartar emetic. EL-RIDY, M., AKBARIEH, M., KASSEM, M., SHARKAWI, M., and TAWASHI, R., Int. J. Pharm., 1989, 56, (1), 23–27.
  • Microencapsulated enzyme systems for the acceleration of cheese ripening. EL-SODA, M., PANNELL, L., and OLSON, N., J. Microencapsul., 1989, 6, (3), 319–326.
  • Retention and subsequent releases of radioactivity from the incineration of wastes containing microspheres. EMERY, R. J., Health-Phys., 1989, 56, (suppl. 1), S29.
  • Temperature-induced fusion of small unilamellar vesicles formed from saturated long-chain lecithins and diheptanoylphosphatidylcholine. Eum, K. M., RIEDY, G., LANGLEY, K. H., and ROBERTS, M. F., Biochemistry, 1989, 28, (20), 8206–8213.
  • Nasal administration of insulin using a microsphere-enhancer delivery system. FARRAJ, N. F., ILLum, L., DAVIS, S. S., and JOHANSEN, B. R., Diabetologia, 1989, 32, (7), 486A.
  • Evidence from ESR studies for virtual immobility in niosomes derived from steroidal lariat ethers. FASOLI, H., ECHEGOYEN, L. E., HERNANDEZ, J. C., GOKEL, G. W., and ECHEGOYEN, L., J. Chem. Soc. Chem. Commun., 1989, (9), 578–580.
  • Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. FATTAL, E., YOUSSEF, M., COUVREUR, P., and ANDREMONT, A., Antimicrob. Agents Chemother., 1989, 33, (9), 1540–1543.
  • Immunization of turkeys against avian influenza with polyvalent liposome-avridine-adjuvanted vaccines. FATUNMBI, 0. 0., NEWMAN, J. A., SIVANANDAN, V., and HALVORSON, D. A., J. Am. Vet. Med. Assoc., 1989, 194, (12), 1797.
  • Spin trapping of lipid-derived radicals in liposomes. FEIX, J. B., and KALYANARAMAN, B., Biochim. Biophys. Acta, 1989, 992, (2), 230–235.
  • Cationic liposome mediated transfection. FELGNER, P. L., HOLM, M., and CHAN, H., Proc. West Pharmacol. Soc., 1989, 32, 115–121.
  • Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles. FERRIS, C. D., HUNGANIR, R. L., SUPATTAPONE, S., and SNYDER, S. H., Nature, 1989, 342, (6245), 87–89.
  • Nanocapsule formation by interfacial polymer deposition following solvent displacement. FESSI, H., PUISIEUX, F., DEVISSAGUET, J. P., AMMOURY, N., and BENITA, S., Int. J. Pharm., 1989, 55, (1), R1–R4.
  • Potent in situ activation of murine lung macrophages and therapy of melanoma metastases by systemic administration of liposomes containing muramyltripeptide phosphatidylethanolamine and interferon gamma. FIDLER, I. J., FAN, D., and ICHINOSE, Y., Invasion Metastasis, 1989, 9, (2), 75–88.
  • Hydrophilic fluorescein derivatives: useful reagents for liposome immunolytic assays. FIECHTNER, M., WONG, M., BIENIARZ, C., and SHIPCHANDLER, M. T., Anal. Biochem., 1989, 180, (1), 140–146.
  • The use of inhaled liposome formulations for drug delivery to the lungs and systemic circulation. FIELDING, R. M., Proc. West Pharmacol. Soc., 1989,32, 103–106.
  • Buffers can modulate the effect of sonication on egg lecithin liposomes. FIORENTINI, D., LAND, L., BARZANTI, V., and CABRINI, L., Free Radic. Res. Commun., 1989, 6, (4), 243–250.
  • Effect of liposomes on hamster oral mucosa. FOONG, W. C., HARSANYI, B. B., and MEZEI, M., J. Biomed. Mater. Res., 1989, 23, (10), 1213–1229.
  • T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads. FRAME, J. N., COLLINS, N. H., CARTAGENA, T., WALDMANN, H., O'REILLY, R. J., DUPONT, B., and KERNAN, N. A., Transplantation, 1989, 47, (6), 984–988.
  • Photoinduced destabilization of bilayer vesicles. FRANICEL, D. A., LAMPARSKI, H., LIMAN, U., and O'BRIEN, D. F., J. Am. Chem. Soc., 1989, 111, (26), 9262–9263.
  • Latex beads as probes of cell surface-extracellular matrix interactions during chondrogenesis: evidence for a role for amino-terminal heparin-binding domain of fibronectin. FRENZ, D. A., AKIYAMA, S. K., PAULSEN, D. F., and NEWMAN, S. A., Dev. Biol., 1989, 136, (1), 87–96. Improved insulin secretion by modified method of rat islet microencapsulation. FRITSCHY, W.
  • M., WOLTERS, G. H. J., GERRITS, D., and SCHILFGAARDE, R., Diabetologia, 1989, 32, (7), 489A. Effects of hydroxyurea on the phagocytosis of microspheres in V79 cells. FUJIKAWA-YAMAMOTO, K., and ODASHIMA, S., Cell Struct. Funct., 1989, 14, (4), 485–493.
  • Conformational study of poly(L-lysine) interacting with acidic phosphilipid vesicles. FUKUSHIMA, K., MURAOKA, Y., INOUE, T., and SHIMOZAWA, R., Biophys. Chem., 1989, 34, (1), 83–90.
  • Liposomes-based immunoassays for detection of small and large molecules. GABER, P., LIGLER, F. S., and BREDEHORST, R., Adv. Exp. Med. Biol., 1988, 238, 214.
  • Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long emulation times. GABIZON, A., SHIOTA, R., and PAPAHADJOPOULOS, D., J. Natl. Cancer Inst., 1989, 81, (19), 1484–1488.
  • Induction of colony-stimulating activity in mice by injection of liposomes containing lipophilic muramyl peptide derivatives. GALELLI, A., CHARLOT, B., PHILLIPS, N. C., and CHEDID, L., Cancer Res., 1989, 49, (4), 810–815.
  • Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat. GALLo, J. M., HUNG, C. T., GUPTA, P. K., and PERRIER, D. G., J. Pharmacokinet. Biopharm., 1989, 17, (3), 305–326.
  • Hematoporphyrin type I (free radical) photosensitizing reactions in liposomes. GANCHEV, Ts., GOCHEV, G., and SHOPOVA, M., Stud. Biophys., 1989, 131, (1-2), 7–20.
  • Safety comparison of insecticide microencapsulation and investigation of its mechanism. GAO, Y. T., and WANG, B. H., J. Microencapsul., 1989, 6, (4), 527–533.
  • Delivery systems for hydrophobic drugs. GARBO, G. M., and MORGAN, A. R., J. Photochem. Photobiol. (B), 1988, 1, (4), 494–495.
  • Immobilization of P. pictorum in open pore agar, alginate and polylysine-alginate microcapsules for serum cholesterol depletion. GAROFALO, F. A., and CHANG, T. M. S., Biomater. Art)'. Cells, Aral Organs, 1989, 17, (3), 271–289.
  • Erythrocyte membrane-bound daunorubicin as a delivery system in anticancer treatment. GAUDREAULT, R. C., BELLEMARE, B., and LACROIX, J., Anticancer Res., 1989, 9, (4), 1201–1205.
  • Multicenter comparative study of two sustained-release formulations of ibuprofen: ibuprofen diffutab tablet 600 mg and microencapsulated ibuprofen 300 mg. GINSBERG, F., BOUEZ, A., COUTELLIER, P., DIVERSE, P., HERMANS, P., RAEMAN, F., SCHUERMANS, Y., TOUSSAINT, M., WARREYNE, R., and FAMAEY, J. P., Curr. Ther. Res. Clin. Exp., 1989, 46, (3), 411–418.
  • D-tryptophan-6-LHRH microcapsules in the treatment of uterine leiomyomas. GOLAN, A., RoN, EL-R., BUKOVSKY, I., HERMAN, A., SCHNEIDER, D., and CASPI, E., Fertil. Steril., 1989,52, (3), 406–411.
  • The interaction of coenzyme Q and vitamin E with multibilayer liposomes. GOMEZ, F. J. C., ARANDA, F. J., VILLALAIN, J., and ORTIZ, A., Adv. Exp. Med. Biol., 1988, 238, 127–139.
  • Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice. GONDAL, J. A., SWARTZ, R. P., and RAHMAN, A., Antimicrob. Agents Chemother., 1989, 33, (9), 1544–1548.
  • Fatty acid spin probe interactions with erythrocyte ghosts and liposomes prepared from erythrocyte ghosts. GORDON, L. M., LOONEY, F. D., and CURTAIN, C. C., J. Membr. Biol., 1989, 111, (2), 155–168.
  • A liposomal MRI contrast agent phosphatidylethanolamine-DPTA. GRANT, C. W., KARLIK, S., and FLORIO, E., Magn. Reson. Med., 1989, 11, (2), 236–245.
  • Physical biochemistry of a liposomal amphotericin B mixture used for patient treatment. GRANT, C. W. M., HAMILTON, K. S., HAMILTON, K. D., and BARBER, K. R., Biochim. Biophys. Acta., 1989, 984, (1), 11–20.
  • Follicle-stimulating hormone receptor-mediated uptake of calcium-45 by proteoliposomes and cultured rat Sertoli cells: evidence for involvement of voltage-activated and voltage-independent calcium channels. GRASSO, P., and REICHERT, L. E. JR., Endocrinology, 1989, 125, (6), 3029–3036.
  • The physiology of the liposome. GREGORIADIS, G., News. Physiol. Sci., 1989, 4, (Aug.), 146–151. Negative enrichment of bovine T lymphocytes with monoclonal antibodies and magnetic microspheres. GRIEBEL, P. J., GEE, A. P., QUALTIERE, L., LAWMAN, M. J., and BABIUK, L. A., Vet. Immunol. Immunopathol., 1989, 22, (2), 161–173.
  • The partition and distribution of porphyrins in liposomal membranes: a spectroscopic study. GROSS, E., and EHRENBERG, B., Biochim. Biophys. Acta., 1989, 983, (1), 118–122.
  • Immobilization of multienzyme system and dextran NAD in semipermeable microcapsules for use in a bioreactor to convert urea into t-glutamic acid. Gu, K. F., and CHANG, T. M. S., In Bioreactor Immobilized Enzymes, and Cells: Fundamentals and Applications, M. Moo-YOUNG, (ed.), (Elsevier Science Publishers Ltd.: Essex, UK), 1988, pp. 59–62.
  • Culture and growth characteristics of chondrocytes encapsulated in alginate beads. Guo, J. F., JOURDIAN, G. W., and MACCALLUM, D. K., Connect. Tissue Res., 1989, 19, (2-4), 277–297.
  • Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats. GUPTA, P. K., and HUNG, C. T., J. Pharm. Sci., 1989, 78, (9), 745–748.
  • Albumin microspheres. II: Applications in drug delivery. GUPTA, P. K., and HUNG, C. T., J. Microencapsul., 1989, 6, (4), 463–472.
  • Albumin microspheres. I: Physico-chemical characteristics. GUPTA, P. K., and HUNG, C. T., J. Microencapsul., 1989, 6, (4), 427–462.
  • Artificial liposomes as a model for studying the lipid peroxidation effect of P-phenylenediamine. GUPTA, V., MISRA, V., and VISWANATHAN, P. N., J. Microencapsul., 1989, 6, (3), 311–318.
  • Stabilization of local anesthetics in liposomes. HABIB, M. J., and ROGERS, J. A., In Pharm. Technol.: Drug Stab., M. H. RUBINSTEIN (ed.). (Horwood: Chichester, UK) 1989, pp. 24–39.
  • Liposomes as carrier for radioactive rhenium complex. HAFELI, U., TIEFENAUER, L., SCHUBIGER, A., and WEDER, H. G., Experientia. Basel., 1989, 45, (Abstr.), A68.
  • A microassay for the determination of soluble, and membrane-bound glutamate decarboxylase activity-influences of cations, lipid compostion, and pyridoxal 5"-phosphate on the glutamate decarboxylase binding to liposomes. HAGEL, C., FLEISSNER, A., and SEIFERT, R., Anal. Biochem., 1989, 182, (1), 64–70.
  • Cancer chemotherapy administered by activated carbon particles and liposomes. HAGIWARA, A., TAKAHASKI, T., ORu, N., and TSUKAGOSHI, S., Crit. Rev. Oncol. Hematol., 1989, 9, (4), 319–350.
  • Binding of 59 kilodalton phytochrome from Avena sadva to liposomes and Cibacron Blue dye. HAHN, T. R., Han'guk Nonghwa Hakhoechi, 1989, 32, (2), 126–131.
  • Distribution of liposome-carried tritiated thymidine in nude mice bearing human renal cell carcinoma xenografts. HALENDA, G., CURLEY, R. M., and JAROWENKO, M. V., Surg. Forum, 1989, 40, 689–691.
  • Thiobarbituric acid-reactive substance formation of rat kidney brush border membrane vesicles induced by ferric nitrilotriacetate. HAMAZAKI, S., OKADA, S., TOYOKUNI, S., and MIDORIKAWA, 0., Arch. Biochem. Biophys., 1989, 274, (2), 348–354.
  • Liposomes: a promising future in dermatology. HANDJANI-VILA, R. M., and GUESNET, J., Ann. Dermatol. Venereol., 1989, 116, (5), 423–430.
  • Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specfic drug delivery to adult T-cell leukemia. HEGE, K. M., DALEICE, D. L., WALDMANN, T. A., and MATTHAY, K. K., Blood, 1989, 74, (6), 2043–2052.
  • Lipid microspheres: preparation technique and characterization. HERNANDEZ-BENAYIDES, P. J., MEDINA-PEREZ, M. M., CEREZO-GALAN, A., and SANCHEZ-MORCILLO, J., Pharmaklinik., 1989, 3, (4), 45–48.
  • Treatment of Brueella inelitensis infection in mice by use of liposome-encapsulated gentamicin. HERNANDEZ-CASELLES, T., VERA, A., VILLALAIN, J., and GOMEZ-FERNANDEZ, J. C., Am. J. Vet. Res., 1989, 50, (9), 1486–1488.
  • IV injection of air-filled human albumin microspheres to enhance arterial doppler signal: a preliminary study in rabbits. HILPERT, P. L., MATTREY, R. F., MITTEN, R. M., and PETERSON, T., Ajr. Am. J. Roentgenol., 1989, 153, (3), 613–616.
  • Targeting of immobilized drugs. HINCAL, A. A., and Kits, H. S., In Nato ASI (Advanced Science Institute) Series: Series C Mathematical and Physical Sciences. Analytical Uses of Immobilized Biological Compounds for Detection, Medical and Industrial Uses, G. G. GUILBAULT and MASCANI (eds.), (Kluwer Academic Publishers: Dordrecht, Netherlands) 1988, Vol. 226, pp. 95–114.
  • An assessment of therapeutic effects by transcatheter arterial embolization (TAE) with degradable starch microspheres (DSM) for hepatic malignant tumors. HIRAI, K., YAMASHITA, K., AOKI, Y., SAKAI, T., ABE, M., TANIKAWA, K., NOGUCHI, H., MIYAZONO, K., Kum., Y., and SAITSU, H., et al. Nippon. Gan. Chiryo. Gakkai. Shi., 1989, 24, (4), 772–780.
  • Progress in liposome studies. HIROTA, S., Pharma. Med., 1989, 7, (7), 85–89.
  • Effects on non-electrolyte molecules with anesthetic activity on the physical properties of DMPC multilamellar liposomes. HITZEMANN, R. J., Biochim. Biophys. Acta, 1989, 983, (2), 205–211.
  • Spontaneous transfer of retinoic acid, retinyl acetate, and retinyl palmitate between single unilamellar vesicles. Ho, M. T., POWNALL, H. J., and HOLLYFIELD, J. G., J. Biol. Chem., 1989, 264, (30), 17759–17763.
  • Kinetic and ultrastructural studies of interactions of target-sensitive immunoliposomes with herpes simplex virus. Ho, R. J. Y., TING-BEALL, H. P., ROUSE, B. T., and HUANG, L., Biochemistry, 1988, 27, (1), 500–506.
  • Mouse interferon-gamma in liposomes: pharmacokinetics, organ-distribution, and activation of spleen and liver macrophages in vivo. HocKERTz, S., FRANKE, G., KNIEP, E., and LOHMANN-MATTHES, M. L., J. Interferon. Res., 1989, 9, (5), 591–602.
  • The present status of liposome production technology. HONDA, H. and HIROTA, S., Prod. Technol. Res. Lab., Daiichi Pharm. Co., Ltd., Tokyo, Japan. 1989, 5, (10), 1171–1178.
  • Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-D-arabinofuranosylcytosine. Hotio, F., and MAYHEW, E., Cancer Res., 1989,49, (18), 5097–5102.
  • Treatment of a murine model of systemic candidiasis with liposomal amphotericin B bearing antibody to Candida albicans. HOSPENTHAL, D., GRETZINGER, K., and ROGERS, A., J. Med. Microbiol., 1989, 30, (3), 193–197.
  • Development of liposomal amphoterecin B bearing anticandidal antibody and use of this preparation in the therapy of a murine model of candidiasis. HOSPENTHAL, D.R., Michigan State University, East Lansing, MI, USA, Dissertation, 1989, pp. 140.
  • Surface charged liposomes as drug carriers and in vivo tests of mice infected with toxoplasma. Hou, X. P., TAO, F., Y1, Y. Y., and WANG, W. L., Yao Hsueh Hsueh Pao, 1989, 24, (1), 53–57.
  • Hepatocellular carcinoma: pilot trial of treatment with yttrium-90 microspheres. HOULE, S., YIP, T. C. K., SHEPHERD, F. A., ROTSTEIN, L. E., SNIDERMAN, K. W., THEIS, E., CAWTHORN, R. H., and RICHMOND-COX, K., Radiology, 1989, 172, (3), 857–860.
  • Use of activated charcoal to adjust serum theophylline concentration after administering sustained-release microcapsules. HUANG-JIN-DING., DUH-VIVIEN-SHW-YUN, CHEN-SHU-HUEY, and YANG-CHYUN-YU. Chun-hua Yao Hsueh Tsa Chili, 1989, 41, (4), 317–323.
  • Multifractal characteristics of magnetic-microsphere aggregates in thin films. HUANG, L. J., Liu, B. X., DING, J. R., and Li, H. D., Phys. Rev. B: Condens. Matter, 1989, 40, (1), 858–861. Monoclonal antibody targeting of liposomes to mouse lung in vivo. HUGHES, B. J., KENNEL, S., LEE, R., and HUANG, L., Cancer Res., 1989, 49, (22), 6214–6220.
  • Encapsulation is not involved in the activities of recombinant gamma interferon associated with multilamellar phospholipid liposomes on murine bone marrow-derived macrophages. HUME, D. A., and NAYAR, R., Lymphokine Res., 1989, 8, (4), 415–425.
  • Synthesis and analytical application of crosslinked styrene-clivinylbenzene copolymer by suspension polymerization of styrene. IDE, S., HARAGUCHI, T., HATANAKA, C., NISHIMIYA, K., and HATATE, Y., Kitakyushu Kogyo Koto Senmon Gakko Kenkyu Hokoku, 1989, 22, 75–79.
  • Planning of LM (lipid microspheres) conjugated B11114 (biological response modifiers). IGARASHI, R., Pharma. Med., 1989, 7, (7), 90–92.
  • Interaction between cytochrome C oxidase and cytochrome c551 from aerobic bacterium Micrococcus lysodeikticus in liposomes. IL'vAsovA, D. I., KAPRECYANTS. A. S., and OSTROVSKII, D. N., Biol. Membr., 1989, 6, (10), 1046–1052.
  • Production and metabolism of cytotoxic phospholipids generated during incubation of liposomes with oxyhemoglobin. INouE, K., ITABE, H., and Kuno, I., Basic Life Sci., 1988, 49, 291–300.
  • Increasing the immunogenicity of influenza virus hemagglutinin by its incorporation in liposomes. ISHBAEVA, R. I., GULYAKO, A. A., SIMONOV, A. N., KLEPPISH, I., MAKHOV, A. M., and KEIARITONENKOV, I. G., Vopr. Virusol., 1989, 34, (2), 237–240.
  • Measurement of dynamic change in pressure based on ultrasonic resonant shift of microcapsules. ISHIARA, K., TANOUCHI, J., FUJII, K., UEMATSU, M., YOSHIDA, Y., Dot, Y., NAGAKURA, T., INOUE, M., CHIHARA, K., and SHIRAE, K., Circulation, 1989, 80, (4, Suppl. 2), 567.
  • Effects of phosphatidylcholines containing furan fatty acid on oxidation in multilamellar liposomes. ISHIL, K., OKAJIMA, H., OKADA, Y., and WATANABE, H., Chem. Pharm. Bull., 1989,37, (5), 1396–1398.
  • Preparation of EGF labelled liposomes and their uptake by hepatocytes. Ismi, Y., ARAMAKI, Y., HARA, T., TSUCHIYA, S., and FUWA, T., Biochem. Biophys. Res. Commun., 1989, 160,(2), 732–736.
  • Core-shell type polymer microspheres prepared by domain fixing of block copolymer films. Isuizu, K., and ONEN, A., J Polym. Sci., Part A: Polyrn. Chem., 1989, 27, (11), 3721–3731.
  • Application of encapsulated enzyme as a continuous packed-bed reactor. Iso, M., SHIRAHASE, T., HANUMURA, S., URUSHIYAMA, S., and Ow, S., J. Microencapsul., 1989, 6, (3), 285–299.
  • Chemoembolization with degradable starch microspheres for liver metastases in colorectal cancer. ITANI, K., YOHISKAWA, T., ()YAMADA, H., TAICANO, H., ICHIKAWA, H., TAINAKA, K., SUGINO, S., and KONDO, M., Gan To Kagaku Ryoho, 1989, 16, (8, Part 2), 2897–2900.
  • Rodent-human microcell hybrids containing retroviral insertions into specific human chromosomes. JACKSON, C. L., GERSEN, S., Yu, M. T., POTTS, A., MARK, H. F. L., WARBUTON, D., and HOUSMAN, D. E., Am. J. Hum. Genet., 1989, 45, (4, Suppl.), A197.
  • Rodent-human microcell hybrids containing single human chromosomes marked with a new retroviral vector. JACKSON, C. L., GERSEN, S., HANDELIN, B., HOUSMAN, D. E., and WARBURTON, D., Cytogenet. Cell Genet., 1989, 51, (1-4), 1018.
  • Microencapsulation using poly(t-lactic acid). I: Microcapsule properties affected by the preparative technique. JALIL, R., and NIXON, J. R., J. Microencapsul., 1989, 6, (4), 473–484.
  • Liposomes and lipid structures as carriers of amphotericin B. JANOFF, A. S., In Current Topics in Infectious Diseases and Clinical Microbiology: Perspectives in Antiinfective Therapy, G. G. JACKSON, H. D. SCHLUMBERGER and H. J. ZEILER (eds) (Friedr. Vieweg and Sohn Verlagsgesellschaft MB H: Braunschweig, West Germany), 1989, Vol. 2, pp. 146–151.
  • Nonspecific cell binding characteristics of paramagnetic polystyrene microspheres used for antibody-mediated cell selection. JANssEN, W. E., and Rios, A. M., J. Immunol. Methods, 1989, 121, (2), 289–294.
  • Hypothalamic phospholipid liposomes in the treatment of the climacteric syndrome. JASONNI, V. M., PALARETI, A., BULLETTI, C., FUSCHINI, C., NALDI, S., and RICCIARDELLI, E., Minerva. Ginecol., 1989, 41, (4), 187–193.
  • Release characteristics of bleomycin, mitomycin C, and 5-fluorouracil from gelatin microspheres. JEYANTHI, R., and RAO, K. P., Int. J. Pharm., 1989, 55, (1), 31–31.
  • A comparison of wax matrix and microencapsulated potassium chloride in relation to upper gastrointestinal illness requiring hospitalization. JicK, H., Jtcx, S. S., WALKER, A. M., and STERGACHIS, A., Pharmacotherapy, 1989, 9, (4), 204–206.
  • Encapsulation of drugs by lyophilized empty dipalmitoylphosphatidylcholine liposomes: effect of calcium ion. jizomoTo, H., and HIRANO, K., Chem. Pharm. Bull., 1989,37, (11), 3066–3069.
  • Interaction of Clostridium perfringens delta toxin with erythrocyte, and liposome membranes and relation with the specific binding to the ganglioside GM2. JOLIVET-REYNAUD, C., HAUTTECOEUR, B., and ALoue, J. E., Toxicon., 1989, 27, (10), 1113–1126.
  • Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits. JoLy, V., DROMER, F., BARGE, J., YENI, P., SETA, N., MOLAS, G., and CARBON, C., J. Pharmacol. Exp. Ther., 1989, 251, (I), 311–316.
  • Reconstitution of red blood cells: cytoskeletons coated with phospholipid membrane. JUNG, C. Y., and CUPPOLETTI, J., Methods Enzymol., 1989, 173, 392–401.
  • Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization. KAHL, L. P., SCOTT, C. A., LELCHUK, R., GREGORIADIS, G., and LIEW, F. Y., J. Immunol., 1989, 142, (12), 4441–4449.
  • Effectiveness of cycloplatam in the free form and included in liposomes during metastasis of GA-1 tumors in A/He mice. KALEDIN, V. I., and CHECTSOV, P. A., Eksp. Onkol., 1989, 11, (5), 74–77.
  • Inhibition of tumor growth in the liver by cis-diamminodichloroplatinum embedded in large oligolamellar liposomes prepared by freezing and thawing. KALEntx, V. I., Nucoux, V. P., POPOVA, N. A., BUDKER, V. G., and SEMENOVA, L. A., Vopr. Onkol., 1989,35, (5), 599–602.
  • Electronic energy transfer in anisotropic systems. 2. 2,5,8,11-Tetra-tert-butylperylene in vesicles. KALMAN, B., JOHANSSON, L. B. A., LINDBERG, M., and ENGSTROEM, S., J. Phys. Chem., 1989, 93, (26), 8371–8376.
  • Methodology for efficacy study of liposome bronchodilators in long duration experiments. KAMEREI, A., WONG, A., and MCCALDEN, T., Proc. West Pharmacol. Soc., 1989, 32, 33–35.
  • Enhancement of both intracellular uptake and antitumor action of cisplatinum on human neuroblastorna cells by encapsulation in liposomes. Kimio, Y., KATO, H., KISHIKAWA, T., TODA, T., SASSAKI, S., ITO, J., KATO, T., and TANAKA, R., Jpn. J. Cancer Res., 1989, 80, (8), 787–793.
  • A proton NMR study of the influence of n-alcohols on the stoichiometry of melittin-induced permeability of phospholipid vesicles. KASZUBA, M., and HUNT, G. R. A., Biochim. Biophys. Acta, 1989, 985, (1), 106–110.
  • Preparation and application of monodisperse PMMA particles. KAWASE, S., Zairyo Gijutsu, 1989, 7, (5), 164–172.
  • Induction of fusion in aggregated and nonaggregated liposomes bearing cationic detergents. KEREN-ZUR, M., BEIGEL, M., and LOYTER, A., Biochim. Biophys Acta, 1989, 983, (2), 253–258.
  • Possible approaches to the development of phospholipid preparations: acceptors of membrane cholesterol. KHALILOV, E. M., TORKHOVSKAYA, T. I., FORTINSKAYA, E. S., KALIMAN, A. M., KOCHETOVA, M. M., PANASENKO, 0. M., ISAMUKHAMEDOVA, A. SH., MARKIN, S. S., and ARCHAKOV, A. I., Byull. Eksp. Biol. Med., 1989, 107, (4), 451–453.
  • Effects of cholesterol- or 7-ketocholesterol-containing liposomes on colony-forming ability of cultivated cells. Knolatt.ov, A. N., PROKHOROV, L. Yu., ZAKHAROVA, T. S., IVANOVA, A. S., KHALILOV, E. M., and ARCHAKOV, A. I., Byull. Eksp. Biol. Med., 1989, 108, (9), 348–349.
  • Filterability of fetal erythrocyte ghosts. KIABARA, M., MAMUMOTO, Y., and MURATA, T., Biorheology, 1989, 26, (3), 574.
  • Novel functionalized liposomes and a process for production thereof. US Patent-4861597; August 29, 1989. KIDA, M., KITABATA, I., KUBOTSU, K., and SAKATA, Y., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1105, (5), 3287.
  • Augmentation of antiproliferative activity of interferon alfa against human bladder tumor cell lines by encapsulation of interferon alfa within liposomes. KILLION, J. J., FAN, D., BUCANA, C. D., FRANGOS, D. N., PRICE, J. E., and FIDLER, I. J., J. Natl. Cancer Inst., 1989, 81,(18), 1387–1392.
  • Electron transfer between liposomal cytochrome cl and cytochrome c: catalytic implications of electrostatic potentials. Km, C. H., KING, T. E., and BALNY, C., Biochem. Biophys. Res. Commun., 1989, 163, (1), 276–283.
  • Development of sustained-release microcapsules containing ion-exchange resin-dextromethorphan hydrobromide complex. KIM-CtioNG-KOOK, HWAMG-SU-WON, HWANG-SUNG-JOO, and LAH-WOON-LYONG., Yakche Hakhoechi, 1989, 19, (2), 99–107.
  • Interaction of alpha-lactalbumin with phospholipid vesicles as studied by photoactivated hydrophobic labeling. KIM-JEONGHA, and KIM-HYOUNGMAN. Biochim. Biophys Acta, 1989, 983, (1), 1–8.
  • Kinetic study on the hydrolysis of p-nitrophenyl palmitate in reconstituted bacteriorhodopsin-DPPC vesicle. KIM-KEox, LEE-Hoo-SEGL, and PARK-JoGN-Woo., Bull. Korean Chem. Soc., 1989, 10, (4), 389–390.
  • Production of hydrogen sulphide in milkfat-coated microcapsules containing Brevibacterium linens and cysteine. KIM, S. C., and OLSON, N. F., J. Microencapsul., 1989, 6, (4), 501–513. Production of methanethiol in milk fat-coated microcapsules containing Brevibacterium linens and methionine. KIM, C., and OLSON. N. F., J. Dairy Res., 1989, 56, (5), 799–811. Metabolism of liposome-encapsulated heparin. KIM, T. D., KAMBAYASHI, J., SAKON, M., TSUJINAKA, T., OHSHIRO, T., and MORI, T., Thromb. Res., 1989, 56, (3), 369–376.
  • Alginate concentration: a key factor in the growth of temperature-sensitive baculovirus-infected insect cells in microcapsules. KING, G. A., DAUGULIS, A. J., GOOSEN, M. F. A., FAULKNER, P., and BAYLY, D., Biotechnol. Bioeng., 1989, 34, (8), 1085–1091.
  • Measurements of ultra-microparticles in a liquid by photoacoustic spectroscopy. KITAMORI, T., and SAWADA, T., Nihon Genshiryoku Gakkaishi, 1989, 31, (5), 558–559.
  • Mutual recognition between polymerized liposomes: macrophage model system by polymerized liposomes. KITANO, H., KATO, N., and IsE, N., J. Am. Chem. Soc., 1989, 111, (17), 6809–6813.
  • Liposoznes coupled with monoclonal antibodies against glioma-associated antigen for targeting chemotherapy of glioma. KITO, A., YOSHIDA, J., KAGEYAMA, N., KormA, N., and YAGI, K., J. Neurosurg., 1989, 71, (3), 382–387.
  • Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidyl-ethenolamine. KLE1NERMAN, E. S., MURRAY, J. L., SNYDER, J. S., CUNNINGHAM, J. E., and FIDLER, I. J., Cancer Res., 1989, 49, (16), 4665–4670.
  • Coupled electron-proton transport in flavolipid functionalized liposome. KEGNE, Y., and HAMACHI, I., J. Chem. Soc. Chem. Commun., 1989, (18), 1300–1302.
  • Effect of degradable starch microspheres (DSM) on hepatic hemodynamics. KOIKE, S., FUJIMOTO, S., GUHJI, M., SHRESTHA, R. D., KOKUBUN, M., KOBAYASHI, K., KIUCHI, S., KONNO, C., and Oxul, K., Gan To Kagaku Ryoho, 1989, 16, (8, Pt 2), 2818–2821).
  • Target cell lysis by cytotoxic T lymphocytes redirected by antibody-coated polystyrene beads.
  • KOLBER, M. A., QUINONES, R. R., and HENKART, P. A., J. Immunol, 1989, 143, (5), 1461–1466. Functional reconstitution of rat ovarian LH-hCG receptor into proteoliposomes. KOLENA, J., FEBS. Lett., 1989, 250, (2), 425–428.
  • Steroidogenesis in liposomal system containing adrenal microsomal cytochrome P-450 electron transfer components. KOMINAMI, S., INOUE, S., HIGucHi, A., and TAKEMORI, S., Biochim. Biophys. Acta, 1989, 985, (3), 293–299.
  • Antitumor effect of IL-2 entrapped in liposomes on rat hepatoma, AH-66. KONNO, H., TORIYAMA, H., AOKI, K., BABA, S., SAKAGUCHI, S., YAMASHITA, A., and TADAKUMA, T., Gan To Kagaku Ryoho, 1989, 16, (1), 53–58.
  • The efficient therapeutic effect of monoclonal antibody conjugated liposomes containing ADM. KONNO, H., SAKAGUCHI, S., KUMAI, K., SUZUKI, H., TSUBOUCHI, T., ISHIBIKI, K., ABE, 0., TADAKUMA, T., YASUDA, T., NAGAIKE, K., et al. Nippon Rinsho, 1989, 47, (6), 1396–1401.
  • Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumours. KONNO, H., KUMAI, K., TSUBOUCHI, T., ISHIBIKI, K., ABE, 0., TADAKUMA, T., YASUDA, T., NAGAIKE, K., HOSOKAWA, S., and SAKAGUCHI, S., Gan To Kagaku Ryoho, 1989, 16, (6), 2213–2217.
  • Platelet adhesion on to polyamide microcapsules coated with lipid bilayer membrane. KONO, K., ITo, Y., KIMURA, S., and IA/Armin, Y Biomaterials, 1989, 10, (7), 455–461.
  • Mellittin interaction with model membranes: influence on size and permeability of liposomes. KOSTRZHEVSKAYA, E. G., SHCHERBATSKAYA, N. V., and VEKLICH, Yu. I., Ukr. Biochim. Zh., 1989, 61, (5), 77–84.
  • In vitro and in vivo evaluation of microcapsules prepared by the powder bed method using acetone as solvent. KOYAMA, I., SHIMANO, K., MAKABE, E., OZAWA, Y., and GOTO, S., Yakuzaigaku, 1989, 49, (3), 247–253.
  • Evaluation of physical properties of microcapsules prepared by the powder bed method using various organic solvents. KOYAMA, I., SHIMANO, K., MAKABE, E., OZAWA, Y., and GOTO, S., Yakuzaigaku, 1989, 49, (3), 234–240.
  • Development and evaluation of equipment for microencapsulation by the powder bed method. KOYAMA, I., SELMAN°, K., MAKABE, E., OZAWA, Y., and GOTO, S., Yakuzaigaku, 1989, 49, (2), 127–132.
  • Introduction of new alcohol binding sites at the lipid/water interface by the incorporation of monosialogangliosides into DPPC liposomes. KREISHMAN, G. P., GRAHAM-BRITTAIN, C., SCHUELER, H. E., and HITZEMANN, R. J., Redox Chem. Interfacial Behav. Biol. Mol, (Proc. Int. Symp. Redox Mech. Interfacial Prop. Mol. Biol. Importance), 3rd, 1987, G. DRYHURST, and K. NIKI, (eds.) (Plenum: New York, N. Y., USA) pp. 631–640.
  • Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles. KREUTER, J., MUELLER, U., and MUNZ, K., Int. J. Pharm., 1989, 55, (1), 39–45.
  • Microencapsulation of indomethacin by pectin-gelatin complex coacervation method. KU-YOUNG-SOON, and CHIN-Soo-YOUNG., Yakhak Hoechi, 1989, 33, (3), 191–202.
  • Increased c ytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone. KUBIAK, C., COUVREUR, P., MANIL, L., and CLAUSSE, B., Biomaterials, 1989, 10, (8), 553–556.
  • Selective and prolonged suppressive effect of liposome-entrapped phenytoin en epileptogenicity in limbic status epilepticus. KUROKOUCHI, A., MORI, N., and KurlssHino, H., Epilepsia, 1989, 30, (5), 647.
  • Study of interaction of polynucleotides with phosphatidylcholine liposomes and bivalent cations by ESR and proton NMR spectroscopy. KUVICHKIN, V. V., VOLKOVA, L. A., NARYSHKINA, E. P., and ISANGALIN, F. SH., Biofizika, 1989, 28, (3), 405–409.
  • Application of surface thermodynamics to the microencapsulation of mammalian cells.
  • LAMBERT', F. V., University of Toronto, Toronto, ON, Canada, Dissertation, 1988.
  • Preparation and evaluation of protein microcapsules for a marine suspension-feeder, Lie Pacific oyster Crassostrea gigas. LANGDON, C. J., Mar. Biol. (Berlin), 1989, 102, (2), 217-224. Liposomes. LASIC, D. D., Recherche, 1989, 212, 904–913.
  • Phospholipid vesicles from mixed micelles of egg yolk lecithin and a zwitterionic detergent (CHAPS). LASIC, D. D., MARTIN, F. J., NEUGEBAUER, J. M., and KRNTOEVIL, J. P., J. Colloid. Interface Sci., 1989, 133, (2), 539–544.
  • Complexing of the bovine serum albumin with phosphatidylcholine liposomes. LEBED, 0. I., PRIMAK, R. G., and TISHCHENKO, R. I., Ukr. Biokhim. Zh., 1989, 61, (3), 101–106.
  • Influence of ultrasonic treatment on characteristics of the forming liposomes. LEBED, 0. 1., STEFANOV, A. V., and PRIMAK, R. G., Ukr. Biokhim. Zh., 1989, 61, (3), 96–101.
  • A rapid-freezing and freeze-fracturing method applied to the aggregation of hapten-bearing liposomes. LEE, K. D., and OWICKI, J. C., J. Electron. Microsc. Tech., 1989, 13, (4), 372–373. Statistical thermodynamics of association colloids. 2. Lipid vesicles. LEERMAKERS, F. A. M., and
  • SCHEUTJENS, J. M. H. M., J. Phys. Chem., 1989, 93, (21), 7417–7426.
  • Liposome mediated gene transfer into liver cells in vivo: a possible therapy model for type 1 insulin-dependent diabetes mellitus. LEIBIGER, I., LEIBIGER, B., SARRACH, D., WALTHER, R., and ZUEHLKE, H., Diabetologia, 1989, 32, (7), 509A.
  • Quinone-functionalized liposomes. Biomimetic assemblies from a phosphatidylcholine anthraquinone. LEIDNER, C. R., and Liu, M. D., . Am. Chem. Soc., 1989, 111, (17), 6859–6860.
  • The kinetics of in vitro release and the pharmacokinetics of miotic response in rabbits of gelatin and albumin microspheres with pilocarpine. LEUCUTA, S. E., Int. J. Pharm., 1989, 54, (1), 71–78.
  • Microcapsules with modulable properties made with cross-linked proteins and polysaccharides. LEVY, M. C., and ANDRY, M. C., Therapie, 1989, 44, (5), 365–369.
  • MHC fully allogeneic bone transplantation after physical T-cell depletion with magnetic microspheres (MAMIS). LEYHAUSEN, G., WINOTO-MORBACH, S., BLANK, M., and MULLER-RUCHHOLTZ, W., Transplant Proc., 1989, 21, (1, Part 3), 2943–2946.
  • A new in vivo anti-viral assay using microencapsulated infected cell cultures. Li, X. Q., GORELIK, E., ATCHISON, R. W., OVEJERA, A., and Ho, M., Antiviral Res., 1988, 10, (4–5), 179–191. Hemolytic holes in human erythrocyte membrane ghosts. LIEBER, M. R., and STECK, T. L., Methods Enzymol., 1989, 173, 356–367.
  • Iron loading modifies the fatty acid composition of cultured rat myocardial cells and liposomal vesicles: effect of ascorbate and alpha-tocopherol on myocardial lipid peroxidation. LINK, G., PINSON, A., KAHANE, I., and HERSHKO, C., J. Lab. Clin. Med.,1989, 114, (3), 243–249.
  • Parameters controlling drug release from pellets coated with aqueous ethyl cellulose dispersion. LIPPOLD, B. H., SUTTER, B. K., and LIPPOLD, B. C., Int. J. Pharm., 1989,54, (1), 15–25.
  • Small, but not large, unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic acid can be stabilized by human plasma. Liu, D., and HUANG, L., Biochemistry, 1989, 28, (19), 7700–7707.
  • Characterization of plasma-stabilized liposomes composed of dioleoylphosphatidyl-ethanolamine and oleic acid. Liu, D., ZHou, F., and HUANG, L., Biochem. Biophys. Res. Commun., 1989, 163, (3), 1539.
  • Efficacy of liposome-bound amphotericin B for the treatment of experimental fungal endophthalmitis in rabbits. Liu, K. R., PEYMAN, G. A., and KHOOBEHI, B., Invest. Ophthalmol. Vis. Sci., 1989, 30, (7), 1527–1534.
  • Separation of the lipid bilayer from the membrane skeleton during discocyte-echinocyte transformation of human erythrocyte ghosts. Liu, S. C., DERICK, L. H., DUQUETTE, M. A., and PALEK, J., Eur. J. Cell Biol., 1989, 49, (2), 358–365.
  • Liposomes in infectious diseases: present and future. LOPEZ-BERESTEIN, G., Curr. Clin. Top. Infect. Dis., 1989, 10, 241–253.
  • Treatment of systemic fungal infections with liposomal amphotericin B. LOPEZ-BERESTEIN, G., BODEY, G. P., FAINSTEIN, V., KEATING, M., FRANKEL, L.S., ZELUFF, B., GENTRY, L., and MEHTA, K., Arch. Intern. Med., 1989, 149, (11), 2533–2536.
  • Liposomes as carriers of antifungal drugs. LOPEZ-BERESTEIN, G., Ann. N. Y. Acad. Sci., 1988, 544, 590–597.
  • Temporary chemoembolization of colorectal liver metastases with degradable starch microspheres. LORENZ, M., HERRMANN, G., KIRKOWA-REIMANN, M., RAUBER, K., HERRHAUSEN, T., HENNE, T., and HOTTENROTT, C., Eur. J Surg. Oncol., 1989, 15, (5), 453–462.
  • Correlation spectroscopy of solid microparticles suspended in aqueous medium. LORUSSO, G. F., MINAFRA, A., CAPOZZI, V., and LOIACONO, D., Hely. Phys. Acta, 1989, 62, (6-7), 900–901.
  • Targeted liposomes bearing Sendai or influenza envelope glycoproteins as a potential carrier for protein molecules and genes. LOYTER, A., In Current Topics in Infectious Diseases and Clinical Microbiology: Perspectives in Antiinfective Therapy, G. G. JACKSON, H. D. SCHLUIVIBERGER and H. J. ZEILER (eds). (Friedr. Vieweg and Sohn Verlagsgesellschaft MBH Braunschweig, West Germany), 1989, Vol. 2, pp. 152–162.
  • Study on dissolution rate of injection of microencapsulated compound megestrol acetate. Lu, B., MENG, J. X., XIE, Z. Y., and Pu, J. X., Hua Hsi I Ko Ta Hsueh Hseuh Pao, 1989, 20, (1), 81–84. Preparation and characterization of polystyrene microcapsules containing corrosion inhibitors. MAC, A., NEGI, D., and FRIEND, D., J. Microencapsul., 1989, 6, (3), 361-368. Nylon microcapsules. II. Effect of selected variables on theophylline release. MADAN, P. L., and
  • CHAREONBOONSIT, P., Pharm. Res., 1989, 6, (8), 714–718.
  • Applicability of an immuno-microsphere technique for a forensic identification of ABO blood types: the use of fluorescent microspheres. MAEDA, H., Nippon Hoigaku Zasshi, 1989, 43, (4), 322–327.
  • Microencapsulation of human diploid fibroblasts in cationic polyacrylates. MALLABONE, C. L., CROOKS, C. A., and SEFTON, M. V., Biomaterials, 1989, 10, (6), 380–386.
  • Cationic liposome-mediated RNA transfection. MAL0NE, R. W., FELGNER, P. L., and VERMA, I. M., Proc. Natl. Acad. Sci. USA, 1989, 86, (16), 6077–6081.
  • Liposomal encapsulation of Cu, Zn superoxide dismutase: characterization of enzyme-loaded liposomes and their interaction with human cells. MARCOCCI, L., LAUDONIO, L., MONDOVI, B., and MAYELLI, I., Ital. J. Biochem., 1989, 38, (4), 275A–278A.
  • Fusion of small unilamellar vesicles with viable EDTA-treated Escherichia coli cells. MARVIN, H. J., TERBEEST, M, B., HOEKSTRA, D., and WITFIOLT, B., J. Bacterial., 1989, 171, (10), 5268–5275. Bioavailability of theophylline-containing polymethylmethacrylate microspheres in rabbits.
  • MARUYAMA, K., PONGPAIBUL, Y., and IWATSURU, M., J. Controlled Release, 1989, 10, (2), 177–182. Fusion of small unilamellar vesicles with viable EDTA-treated Escherichia coli cells. MARVIN, H. J., TERBEEST, M. B., HOEKSTRA, D., and WITHOLT, B., J. Bacteriol, 1989, 171, (10), 5268–5275. Assay of complement activity in human serum using large unilamellar liposomes. MASAKI, T., OKADA, N., YASUDA, R., and OKADA, H., J. Immunol. Methods, 1989, 123, (1), 19–24.
  • Advanced techniques for preparation and characterization of small unilamellar vesicles. MASSON, G., Food Miscrostruct., 1988, 8, (1), 11–14.
  • Synthetic polymer microcapsules. MASUDA, T., Kobunshi Kako, 1989, 38, (6), 293–298.
  • The effect of cholesterol content of phospholipid vesicles on the encapsulation and acid resistance of beta-galactosidase from E. coli. MATSUZAKI, M., MCCAFFERTY, F., and KAREL, M., Int. J. Food Sci. Technol., 1989, 24, (4), 451–460.
  • Role of ligand in antibody-directed endocytosis of liposomes by human T.-leukemia cells. MATTHAY, K. K., ABAI, A. M., COBB, S., HONG, K., PAPAHADJOPOULOS, D., and STRAUBINGER, R. M., Cancer Res., 1989, 49, (17), 4879–4886.
  • Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. MAYER, L. D., TAI, L. C., Ko, D. S., MASIN, D., GINSBERG, R. S., CULLIS, P. R., and BALLY, M. B., Cancer Res., 1989, 49, (21), 5922–5930.
  • Effects of microencapsulated monosialoganglioside GM1 on cholinergic neurons. MAYSINGER, D., GAROFALO, L., JALSENJAK, I., and CUELLO, A. C., Brain Res., 1989, 496, (1–2), 165–172. The liposome in pharmacology. MCCALDEN, T. A., Proc. West Pharmacol. Soc., 1989, 32, 101–102. Implantable microencapsulated dopamine (DA): a new approach for slow-release DA delivery into brain tissue. MCRAE-DEGUERCE, A., HJORTH, S., DILLON, D. L., MASON, D. W., and TICE, T. R., Neurosci. Lett., 1988, 92, (3), 303–309.
  • Study of freezing as a liposome preservation method: effect of the addition of cryoprotective agents. MEDINA-PEREZ, M. D. M., CEREZO-GALAN, A., and SANCHEZ-MORCILLO, J., Pharmaklinik., 1989, 3, (3), 47–48. 50–52.
  • Tocopheroxyl radical persistence and tocopherol consumption in liposomes and in vitamin E-enriched rat liver mitochondria and microsomes. MEHLHORN, R. J., SUMIDA, S., and PACKER, L., J. Biol. Chem., 1989, 264, (23), 13448–13452.
  • Interaction of liposome-encapsulated retinoicis with normal and leukemic cells. MEHTA, K., In Pharmacology and the Skin: Pharmacology of Retinoids in the Skin, U. REICHERT, and B. SHROOT (eds). (Karger AG: Basel, Switzerland), 1989, Vol. 3, pp. 74–80.
  • Liposomes as drug carriers for polyene antibiotics. MEHTA, R. T., Adv. Drug Delivery Rev., 1989,3, (3), 283–306.
  • A comparison of in vitro toxicity and antifungal efficacy of membrane-active drugs after liposome encapsulation. MEHTA, R. T., HOPFER, R. L., JULIANO, R. L., and LOPEZ-BERESTEIN, G., Se. Cancer Ther., 1989,5, (3), 113–117.
  • Liposomal pulmonary drug delivery I. In vivo disposition of atropine base in solution and liposomal form following endotracheal instillation to the rabbit lung. MEISNER, D., PRINGLE, J., and MEZEI, M., J. Microencapsul., 1989, 6, (3), 379–388.
  • Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine. MEISNER, D., PRINGLE, J., and MEZEI, M., Int. J. Pharm., 1989, 55, (2-3), 105–113.
  • Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity. MELLORS, J. W., DEBS, R. J., and RYAN, J. L., Infect. Immun., 1989, 57, (1), 132–137.
  • A new approach to encapsulating nonsteroidal anti-inflammatory drugs III. Coating acidic as well as basic nonsteroidal anti-inflammatory drugs with cellulose derivatives having different functional groups. MESHALI, M. M., EL-DIEN, E. Z., OMAR, S. A., and Luzzt, L. A., J. Microencapsul., 1989, 6, (3), 339–354.
  • Etretinate incorporated into phospholipid liposomes. MICHAELIS, L., WEBER, U., SCHROEDER, E., and MELNIK, B., In Pharmacology and the Skin: Pharmacology of Retinoids in the Skin, U. REICHERT, and B. SHROOT (eds). (Karger AG: Basel, Switzerland), 1989, Vol. 3, pp. 201–202.
  • Enhanced fluctuations in small phospholipid bilayer vesicles containing cholesterol. MICHELS, B, FAZEL, N., and CERF, R., Eur. Biophys. J., 1989, 17, (4), 187–190.
  • Microbeads and anchorage-dependent eukaryotic cells: the beginning of a new era in biotechnology. MILLER, A. 0. A., MENOZZI, F. D., and DUBOIS, D., Adv. Biochem. EnglBiotechnol., 1989, 39, 73–95.
  • Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies. Mium, T., and HAIDA, K., Gan To Kagaku Ryoho, 1989, 16, (8, Part 2), 2822–2826.
  • Possible therapeutic effect of naftidrofuryl oxalate on brain energy metabolism after microsphere-induced cerebral embolism. MIYAKE, K., TANONAKA, K., MINEMATSU, R., INOUE, K., and TAICEO, S., Br. J. Pharmacol., 1989, 98, (2), 389–396.
  • Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. MOGHIMI, S. M., and PATEL, H. M., Biochim. Biophys. Acta, 1989, 984, (3), 384–387.
  • Hydrodynamic chromatography for characterization and purification of liposomes. MOLINA-LUCAS, F. J., VILA-Buse., A. 0., DIEGUEZ-BOSCH, P., and FIGUERUELO-ALEJANO, J. E., J. High Resolut. Chromatogr., 1989, 12, (8), 560–561.
  • Effect of chemoembolization of albumin microspheres containing mitomycin C on AH 272 liver metastasis in rats. MORIMOTO, Y., NATSUME, H., SUGIBAYASHI, K., and FUJIMOTO, S., Int.
  • J. Pharm., 1989, 54, (1), 27–32.
  • Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages. MULLER, C. D., and SCHUBER, F., Biochim. Biophys. Acta, 1989, 986, (1), 97–105.
  • Effect of microencapsulation of accessory sperm in the zona pellucida. MUNKITTRICK, T. W., NEBEL, R. L., WHITMAN, S. S., and SMOTHERS, C. D., Dairy Sci., 1989, 72, (8), 2206.
  • Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients. MURRAY, J. L., KLEINERMAN, E. S., CUNNINGHAM, J. E., TATOM, J. R., ANDREJCIO, K., LEPE-ZUNIGA, J., LAMKI, L. M., ROSENBLUM, M. G., FROST, H., GUTTERMAN, J. U., etal. J. Clin. Oncol., 1989, 7, (12), 1915–1925.
  • Study of liposomal pentacine effectiveness in acute experimental intoxication of animals with cadmium chloride. MUZYA, G. I., DUDKIN, S. M., DOGADKINA, N. D., and KULIKOV, V. I., Gig. Tr. Prof. Zabol., 1989, (9), 55–56.
  • Cytochrome P-450 in proteoliposomes: the oligomeric structure of isoform LM 2. MYASOEDOVA, K. N., and BERNDT, P., Biokhimiya, 54, (9), 1445-1456.
  • Effect of transmembrane difference of electrical potentials on photoinduced separation of charges in membranes of liposomes. NADTOCHENKO, V. A., RUBTSOV, I. V., BARANNIKOVA, YA-V., and NIICANDROV, V. V., Dokl. Akad. Nauk. SSSR., 1989, 306, (5), 1256–1261.
  • ESR study on synthetic glyceroglycolipid liposomal membranes. NAITO, M., UTSUMI, H., UMEDA, M., KUDO, I., TAKESHITA, K., HAMADA, A., NOJIMA, S., and INouE, K., Biochim. Biophys. Acta, 1989, 985, (2), 147–152.
  • Reconstitution of calcium channel protein isolated from porcine ventricular muscle into liposomes and its characterization. NAITOH, T., TOYO-OKA, T., and SUGIMOTO, T., Jpn. Circ. J., 1989, 53, (6), 530.
  • Studies on preparation of porous microsphere of metal oxides by interfacial reaction. NAKAHARA, Y., Nippon Kinzoku Gakkai Kaiho, 1989, 28, (6), 459–466.
  • Heat- and solvent-resistant inorganic microcapsules with weatherability. Preparation and application. NAKAHARA, Y., Nippon Setchaku Kyokaishi, 1989, 25, (7), 274–279.
  • Antileishmanial effect of free and encapsulated sinefungin against Leishmania donovani infections in BALB/c mice. NEAL, R. A., IWOBI, M. V., and ROBERT-GERO, M., C. R. Acad. Sci. (III), 1989, 308, (18), 485–488.
  • Bromocriptine microcapsules inhibit omithine decarboxylase activity induced by Freund's complete adjuvant in lymphoid tissues of male rats. NEIDHART, M., Endocrinology, 1989, 125, (6), 2846–2852.
  • Liposome fusion catalytically induced by phospholipase C. NIEVA, J. L., GON1, F. M., and Atom°, A., Biochemistry, 1989, 28, (18), 7364–7367.
  • Preparation of nanoparticles conjugated with enzyme and antibody and their use in heterogeneous enzyme immunoassays. NILSSON, K. G., J. Immunol. Methods, 1989, 122, (2), 273–277.
  • Microcell fusion studies to identify the chromosomes involved in cellular growth control.
  • NING, Y., GARCIA-HERRAS, M., LEDBETTER, D. H., and PEREIRA-SMITH, 0. M., J Cell Biol., 1989, 109, (4, Part 2), 24A.
  • Preparation and release characteristics of cisplatin albumin microspheres containing chitin and treated with chitosan. NISHIOKA, Y., KYOTANI, S., MASUI, H., OKAMURA, M., MIYAZAKI, M., OKAZAKI, K., OHNISHI, S., YAMAMOTO, Y., and ITO, K., Chem. Pharm. Bull., 1989, 37, (11), 3074–3077.
  • The use of circular dichroism active phospholipid to study lipid transfer between liposomes: effects of cholesterol and melittin on spontaneous lipid transfer. NISHIYA, T., and CFIANG, T. M. S., Chem. Phys. Lipids, 1989, 51, (2), 83–90.
  • Complex liposomes. NUSIMOVICH, A. D., and CASADO, F. J., Drug Cosmet. Ind., 1989, 145, (3), 37-38. Microparticles as potentially orally active immunological adjuvants. O'HAGAN, D. T., PALIN, K., DAVIS, S. S., ARTURSSON, P., and SioxoLm, 1., Vaccine, 1989, 7, (5), 421–424.
  • Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals. OGAWA, Y., OKADA, H., HEYA, T., and SHIMAMOTO, T., J. Pharm. Pharmacol., 1989, 41, (7), 439–444.
  • Designs for controlled-release preparations of peptide hormones. OGAWA, Y Kagaku, Zokan (Kyoto), 1989, (116), 223–234.
  • Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors. OGIHARA-UMEDA, I., and KopmA, S., Eur. J. Nucl. Med., 1989, 15, (9), 612–617.
  • Prolonged antiepileptic effects of liposome-entrapped valproic acid on kindled amygdaloid seizure in rats. OHTA, S., MORI, N., and KUMASHIRO, H., Shinkei Seishin Yakuri., 1989, 11, (8), 641–647.
  • Effect of liposome-entrapped lidocaine on status epilepticus in rats OKA, M., KUROKOUCHI, A., Mom, N., and KUMASHIRO, H., Epilepsia, 1989, 30, (5), 647.
  • One-month release injectable microspheres of leuprolide acetate inhibit steroidogenesis and genital organ growth in rats. OKADA, H, HEYA, T., IGARI, Y., OGAWA, Y., TOGUCHI, H., and SHIMAMOTO, T., Int. J. Pharm., 1989, 54, (3), 231–239.
  • Polymer cation effect on the stability to electrolytes of an ethanol-acrylate methacrylate-water coacervated system. OKOR, R. S., J. Macromol. Sci. Phys., 1989, B28, (3–4), 365–374.
  • Studies on suspension and emulsion. CVIII. XPS analysis (ESCA) of the surface composition of poly(styrene/2-hydroxyethyl methacrylate) microspheres produced by emulsifier-free emulsion polymerization. ()KUM, M., YAMAMOTO, Y., and KAmEi, S., Colloid. Polym. Sci., 1989, 267, (10), 861–865.
  • Electric conductive zinc oxide particles microencapsulated with carbon film. OKUMA, N., UCHIDA, S., OGURA, H., and KATO, M., Zairyo, 1989, 38, (425), 182–186.
  • Studies on zinc sulfate microcapsules: (III) in vivo evaluation. ONER, L., ARCASOY, A., KAS, H. S., and HINCAL, A. A., Eur. J. Drug Metab. Pharmcokinet., 1989, 14, (2), 107–110.
  • Use of liposomes as injectable-drug delivery system. OSTRO, M. J., and Cuws, R., Am. J. Hosp. Pharm., 1989, 46, (8), 1576–1587.
  • Fusion and lipid exchange between influenza viruses and liposomes measured with the R18 membrane marker. OTT-VON-WERDT, S., and WUNDERLI-ALLENSPACH, H., Experientia., 1989, 45, (Abstr.), A45.
  • Chemo-embolization using degradable starch microspheres and regional hyperthermia in unresectable hepatocellular carcinoma. ()YAMADA, H., YOSHIKAWA, T., ITANI, K., ICHIKAWA, H., TAINAKA, K., SETO, 0., SUGINO, S., and KONDO, M., Gan To Kagaku Ryoho,1989, 16, (8, Part 2), 3070–3074.
  • Preparation and stability of liposomes containing 5-fluorouracil. OZER, A. Y., and TALSMA, H., Int. J. Pharm., 1989, 55, (2-3), 185–191.
  • Evaluation of Eudragit Retard microcapsules. I: Process parameter study for microencapsulation of sulfamethoxazole. PAL, P.R., and PAL, T. K., Indian Drugs, 1989, 26, (12), 709–712.
  • Pyrene phospholipid as a biological fluorescent probe for studying fusion of virus membrane with liposomes. PAL, R., BARENHOLZ, Y., and WAGNER, R. R., Biochemistry, 1988, 27,(1), 30–36.
  • Direct inhibition of inosito1-1,4,5-trisphosphate induced release from brain microsomes by potassium channel blockers. PALADE, P., DETTBARN, C., VOLPE, P., ALDERSON, B., and OTERO, A. S., Mol. Pharmacol., 1989, 36, (4), 664–672.
  • Liposome vectors for transgenic animal production. PALSY. S. I. J., MINHAS, B. S., ROUDEBUSH, W. E., ROBERTSON, J. L., and Dor:Go/4, M. G., J. Dairy Sci., 1989, 72, (Suppl. 1), 354.
  • Microencapsulated xanthine oxidase as experimental therapy in Lesch-Nyhan disease (letter). PALMOUR, R. M., GOODYER, P., READE, T., and CHANG, T. M., Lancet, 1989, 2, (8664), 687–688.
  • Production of methyl ketones in milkfat-coated microcapsules containing free fatty acids and Penicillium roqueforti spores. PANNELL, L. A., and OLSON, N. F., J. Dairy Sci., 1989, 72, (Suppl. 1), 117.
  • Radioprotective effectiveness of adeturone encapsulated in liposomes. PANTEV, T., Rentgenol. Radio., 1989, 28, (1), 61–65.
  • Effect of phosphatidylcholine on the alpha-lactalbumin-induced fusion of vesicles. PARK, B. S., Km, J., KIM, U. H., and KIM, H., Lipids, 1989, 24, (10), 854–858.
  • Conformation of proline-containing basic peptides in the presence of liposomes and their biological activities. PARK, N. G., KATO, T., LEE, S., and AOYAGI, H., Pept. Chem., 1989, 26th 267–272.
  • Therapeutic effect of chloroquine (CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ. PEETERS, P. A., BRUNINK, B. G., ELI/sic, W. W., and CROMMELIN, D. J., Biochim. Biophys. Acta, 1989, 981, (2), 269–276.
  • Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria. PEETERS, P. A., DE-LEEST, K., ELING, W. M., and CROMMELIN, D. J., Pharm. Res., 1989, 6, (9), 787–793.
  • Liposomes as carriers of antitumor agents toward a clinical reality. PEREZ-SOLER, R., Cancer Treat. Rev., 1989, 16, (2), 67–82.
  • Liposome compositions of anthracycline derivatives. US Patent-4863739; September 5, 1989. PEREZ-SOLER, R., PRIEBE, W., and LOPEZ-BERESTEIN, G., Off. Gay. US Pat. Trademark Off. Pat., 1989, 1106, (1), 426.
  • Interactions of liposomes with planar bilayer membranes. PERIN, M. S., and MACDONALD, R. C., J. Membr. Biol., 1989, 109, (3), 221–232.
  • Microencapsulated alachlor and its behavior on wheat (Triticurn aestivum) straw. PETERSEN, B. B., and SHEA, P. J., Weed Sci., 1989, 37, (5), 719–723.
  • Intravitreal liposome-encapsulated drugs: a preliminary human report. PEYMAN, G. A., CHARLES, H. C., Liu, K. R., KHOOBEHI, B., and NIESMAN, M., Int. Ophathalmol., 1988, 12, (3), 175–182.
  • Liposomes as immune adjuvants. PHILLIPS, N. C., Proc. West Pharmacol. Soc., 1989, 32, 107-110. Fourier transform infrared assay of liposomal lipids. PIDGEON, C., APOSTOL, G., and MARKOVICH, R., Anal. Biochem., 1989, 181, (1), 28–32.
  • Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells. PINNADUWAGE, P., SCHMITT, L., and HUANG, L., Biochim. Biophys. Acta, 1989, 985, (1), 33–37.
  • Nanoparticles as modifier systems on distribution and releasing of drug. PONS-I-LLAMBES, SABATE-I-GRAELL, J., and SUNE-I-NEGRE, J., Pharmaklinik, 1989, 3, (4), 35–44.
  • Comparison of iron-59 labeled superparamagnetic nanoparticle and microcapsule kinetics in MR liver imaging. POULIQUEN, D., PERDRISOT, R., ERMIAS, A., AKOKA, S., JALLET, P., and LE-JEUNE, J. J., Eur. J. Nucl. Med., 1989, 15, (8), 565.
  • Improvement in MR imaging of liver disease using magnetite dextran nanoparticles. POULIQUEN, D., PERDRISOT, R., ERMIAS, A., AKOKA, S., JALLET, P., and LE-JEUNE, J. J., Eur. J. Nucl. Med., 1989, 15, (8), 564.
  • Suppression of mating in Ephestia cautella (Walker) (Lepidoptera: Phycitidae) using microencapsulated formulations of synthetic sex pheromone. PREVETT, P. F., BENTON, F. P., HALL, D. R., HODGES, R. J., and SERODIO, R. S., J. Stored Prod. Res., 1989, 25, (3), 147–154.
  • Enhanced effectiveness of intraperitoneal antibiotics administered via liposomal carrier. PRICE, C. I., HORTON, J. W., and BAXTER, C. R., Arch. Surg., 1989, 124, (12), 1411–1415.
  • An integration of cultivation and purification in membrane bioreactors: production of monoclonal antibodies and lymphokines by microencapsulated hybridomas. PROKOP, A., Mol. Biother, 1988, 1, (2), 61–73.
  • Correlation of enzyme activities with fluorescence anisotropy of dansyl-labeled cytochrome b5/NADH-cytochrome-b5 reductase systems in phosphatidylcholine vesicles. Pucii, E. L., KATES, M., SZABO, A. G., and KRAJCARSKI, D. T., Biochim. Biophys. Acta, 1989, 985, (3), 255–265.
  • Mapping neuronal inputs to r.e.m. sleep induction sites with carbachol-fluorescent microspheres. QUATTROCHI, J. J., MAMELAK, A. N., MADISON, R. D., MACKLIS, J. D., and HonsoN, J. A., Science, 1989, 245, (4921), 984–986.
  • Characterization of hemodynamic, hematologic, and biochemical responses to administration of liposome-encapsulated hemoglobin in the conscious, freely moving rat. RABINOVICI, R., RUDOLPH, A. S., and FEUERSTEIN, G., Circ. Shock, 1989, 29, (2), 115–132.
  • Anti-laminin receptor antibody targeting of liposomes with encapsulated doxorubicin to human breast cancer cells in vitro. RAHMAN, A., PANNEERSELVAM, M., GUIRGUIS, R., CASTRONOVO, V., SOBEL, M. E., ABRAHAM, K., DADDONA, P. E., and LIOTTA, L. A., J. Natl. Cancer Inst., 1989, 81, (23), 1794–1800.
  • The polyene antibiotic amphotericin B acts as a calcium ionophore in sterol-containing liposomes. RAMOS, H., ATTIAS-DE-MURCIANO, A., COHEN, B. E., and BOLARD, J Biochim. Biophys. Acta, 1989, 982, (2), 303–306.
  • Evaluation of liposome-encapsulated clindamycin in Staphylococcus aureus endophthalmitis. RAO, V. S., PEYMAN, G. A., KHOOBEHI, B., and VANGIPURAM, S., Int. Ophthalmol., 1989, 13, (3), 181–185.
  • The modulatory effect of lipoproteins on the release of interleukin 1 by human peritoneal macrophages stimulated with beta-1,3-n-polyglucose derivatives. RASMUSSEN, L. T., and SELJELID, R., Scand. J. Immunol., 1989, 29, (4), 477–484.
  • Sterilization of contrast media (Isovist) containing liposomes by ethylene oxide. RATZ, H., FREISE, J., MAGERSTEDT, P., SCHAPER, A., PREUGSCHAT, W., and KEYSER, D., J. Microencapsul., 1989, 6, (4), 485–492.
  • Proton flux in large unilamellar vesicles in response to membrane potentials and pH gradients. REDELMEIER, T. E., MAWR, L. D., WoNG, K. F., BALLY, M. B., and CuLus, P. R., Biophys. J., 1989, 56, (2), 385–394.
  • Preparation and in vitro activity of liposome encapsulated opioids. REIG, F., ALSINA, M. A., BUSQUETS, M. A., VALENCIA, G., and GARCIA-ANTON, J. M., J. Microencapsul., 1989, 6, (3), 277–284.
  • Microcapsule formation in the cells of Neisseria ineningitidis group B. RESHILOV, L. N., SALov, V. F., BASNAK'IAN, I. A., KARABAK, V. I., BOROVKOVA, V. M., DUBININA, G. P., and SIVTSEVA, L. D., Zh. Mikrobiol. Epidemiol. Immunobiol., 1989, (5), 20–26.
  • Luteinizing hormone concentrations in serum of postpartum beef cows injected with microencapsulated luteinizing hormone-releasing hormone analog. ROBERTS, A. J., CHANG, C. F., SCHALLY, A. V., and REEVES, J. J., J. Anim. Sci., 1989, 67, (10), 2730–2734.
  • The production of stable, protein-coated microspheres. ROBERTS, M. J. J., WILLIAMS, P., DAVIS, S. S., and DAVIES, M. C., J. Colloid. Interface Sci., 1989, 132, (2), 585–588.
  • Clinical pharmacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free nanoparticle-bound anthracycfine. ROLLAND, A., Int. J. Pharm., 1989, 54, (2), 113–122.
  • Cell-density-dependent lysis and sporulation of Myrococcus xanthus in agarose microbeads. ROSENBLUH, A., NIR, R., SAHAR, E., and ROSENBERG, E., J. Bacteriol., 1989, 171, (9), 4923–4929.
  • Effect of electrolytes, stirring and surfactants in the coacervation and microencapsulation processes in presence of gelatin. ROZENBLAT, J., MAGDASSI, S., and GARTI, N., J. Microencapsul., 1989, 6, (4), 515–526.
  • The stability and shelf-life of liposome encapsulated hemoglobin: a potential blood substitute. RUDOLPH, A. S., STRATTON, L. P., KNOLL, W. K. JR, BAYNE, S., and LIGLER, F., Mater Res. Soc. Symp. Proc., 1988, 110, 153–158.
  • Charge distribution in poly(N,N-L-lysinediylterephthaloyl) microcapsule membranes. SAKUMA, S., OHSHIMA, H., and KONDO, T., J. Colloid. Interface Sci., 1989, 133, (1), 253–256.
  • Fixed-charge distribution within the membrane of poly(N,N-L-lysinediyIterephthaloy1) microcapsules. SAKUMA, S., OHSHIMA, H., and KONDO, T., Hyomen Kagaku, 1989, 10, (3), 202–205.
  • Measurement of splanchnic and systemic hemodynamics in mice using a radioactive microsphere technique. SARIN, S. K., SABBA, C., and GROSZMANN, R. J., Hepatology, 1989, 10, (4), 717.
  • Immune parameters of peripheral blood in chemoembolization with microencapsulated anticancer drugs. SATO, K., ABE, R., MORIYAMA, M., KATO, T., and TSUCHIDA, S., Gan To Kagaku Ryoho, 1989, 16, (1), 73–77.
  • Targetability of cell-specific liposomes coated with polysaccharide-cholesterol derivatives. SATO, T., Nippon Rinsho, 1989, 47, (6), 1402–1407.
  • Arrest and retention of multilamellar liposomes in the brain of normal mice or mice bearing experimental brain metastases. SCHACKERT, G., FAN, D., NAYAR, R., and FIDLER, I. J., Sel. Cell Ther., 1989, 5, (2), 73–80.
  • Liposome preparations: a step forward in topical drug therapy for skin disease? A review. SCHAFER-KORTING, M., KORTING, H. C., and BRAUN-FALCO, 0., J. Am. Acad. Dermatol., 1989, 21, (6), 1271–1275.
  • Prevention of nonspecific lysis in liposomal and erythrocyte immunoassay systems by small lipid vesicles and erythrocyte ghosts. SCHREIER, H., VALENTINO, K., HEATH, B. P., and KUNG, V. T., Life Sci., 1989, 45, (20), 1919–1930.
  • The design and in vitro release characterization of human crosslinked hemoglobin microcapsules containing doxorubicin for potential chemoembolization use. SCHUTZ, M., and BENITA, S., J. Dispersion Sci. Technol., 1989, 10, (3), 219–239.
  • Neutrophil-mediated transfer of polar substances from liposomes to mammary tumor cells in vitro. SCIESZKA, J. F., AEED, P. A., WELCH, D. R., and Clio, M. J., Int. J. Pharm., 1989, 53, (2), 167–174.
  • Successful treatment with liposomal amphotericin B in two patients with persisting fungemia. SCULIER, J. P., BRON, D., COUNE, A., and MEUNIER, F., Eur. . J. ain. Microbiol. Infect. Dis., 1989,8, (10), 903–907.
  • Interactions of human lymphoblasts with targeted vesicles containing Sendai virus envelope proteins. SECHOY, 0., VIDAL, M., PHILIPPOT, J. R., and BIENVENUE, A., Exp. Cell Res., 1989, 185, (1), 122–131.
  • The effect of liposome-entrapped desferrioxanaine on Leishtnania donovani in vitro. SEGOVIA, M., NAVARRO, A., and ARTERO, J. M., Ann. Trop. Med. Parasitol., 1989, 83, (4), 357–360.
  • Comparative effect on humoral response of four different proteins covalently linked on BSA-containing liposomes. SHAHUM, E., and THERIEN, H. M., Cell Immunol., 1989, 123, (1), 36–43.
  • Therapeutic intra-arterial administration of yttrium-90 glass microspheres for hepatic tumors. SHAPIRO, B., ANDREWS, J., FIG, L., CAREY, J., WALKER-ANDREWS, S., SMITH, J., and ENSMINGER, W., Eur. J. Nucl. Med., 1989, 15, (8), 401.
  • Ultrastructural study of capillary permeability of liposome-encapsulated cisplatin in an experimental rat brain tumor model. SHIBATA, S., PNNOUCHI, T., and MORI, K., Neurol. Med. Chir. (Tokyo), 1989, 29, (8), 696–700.
  • Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation. SHIKAMA. Y., KOBAYASHI, K., KASAHAFtA, K., KAGA, S., HASHIMOTO, M., YONEYA, I., HOSODA, S., SOEJIMA, K., IDE, H., and TAKAHASHI, T., Am. J. Pathol., 1989, 134, (6), 1189–1199.
  • Anticancer effect of liposome incorporated with methotrexate and antibody against tumor specific surface antigen of rat hepatoma. SHIN, Y. S., PAIK, E. M., AHN, Y. H., KIM, B. S., and Kim, Y. S., Yonsei Med. J., 1989, 30, (3), 246–255.
  • Application of poly(virtyl alcohol) to microencapsulation process. SHIRAISHI, M., Kenkyu Hokoku Kumamoto Kogyo Daigaku, 1989, 14, (1), 157–163.
  • Cell adhesion and growth on synthetic hydrogel beads. SHIVAKUMAR, K., NAIR, R. R., JAYAKRISHNAN, A., KARTHA, C. C., and VALIATHAN, M. S., Bull. Mater Sci., 1989, 12, (1), 27–32. On the dynamics of hydration of proteins inserted into liposomes. SHIYAN, A. A., and MALYUTA, N. P., Biol. Nauki. (Mosc), 1989, (5), 107–111.
  • Visual detection of microencapsulated insecticides with selective staining and scanning electron microscopy. SIBLEY, P. K., and FORTIN, C., J. Econ. Entomol., 1989, 82, (5), 1323–1327.
  • Binding of 124-kilodalton oat phytochrome to liposomes and chloroplasts. SINGH, B. R., CHOI, J. K., Kim, 1. S., and SONG, P. G., Physiol. Plant, 1989, 76, (3, Part 1), 319–325.
  • The use of microspheres to improve paper properties. SOEDERBERG, 0., Pap. Technol., 1989,30, (8), 17–21.
  • Experience in BARC on the preparation of gel microspheres of uranium, thorium, and plutonium fuels. Soon, D. D., and VAIDYA, V. N., Mater Sci. Forum, 1989, 48–49. 245–255.
  • /n vitro and in vivo degradation of poly(DL-lactideiglycolide) type microspheres made by solvent evaporation method. SPENLEHAUER, G., VERT, M., BENOIT, J. P., and BODDAERT, A., Biomaterials, 1989, 10, (8), 557–563.
  • Development of cationic liposomes to transfer proteins between membranes. STAMATOTOS, L., McGill University, Montreal, PQ, Canada. Dissertation, 1988, No pagination.
  • Liposomes for targeted delivery of radioiodinated IVdU and 3-CH3-lVdU for non-invasive detection of herpes simplex virus encephalitis in mice. STATHAKI, S., WIEBE, L. I., KNAUS, E. E., ROGERS, J. A., TOVELL, D., and TYRELL, D. L., Drug Des. Deliv., 1988, 3 (3), 223–234.
  • Influence of surface charge on the incorporation and orientation of cytochrome c oxidase in liposomes. STEVERDING, D., THIEL, C., KADENBACH, B., CAPITANIO, N., and PAPA, S., FEBS Lett., 1989, 257, (1), 131–133.
  • Liposome encapsulation of doxorubicin pharmaceutical and therapeutic aspects. STORM, G., VAN-BLOOIS, L., STEERENBERG, P. A., VAN-ETTEN, E., DE-GROOT, G., and CROMMELIN, D. J. A., J. Controlled Release, 1989, 9, (3), 215–230.
  • A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.
  • STORM, G., VAN-HOESEL, Q. G., DE-GROOT, G., KOP, W., STEERENBERG, P. A., and HILLEN, F. C., Cancer Chemother. Pharmacol., 1989, 24, (6), 341–348.
  • Effect of the entrapment of procaine hydrochloride in liposome on local anesthetic activity. STOZEK, T., and KROWCZYNSKI, L., Pharmazie, 1989, 44, (7), 466–468.
  • Polymerizable liposome-forming lipid and method for production thereof. US Patent-4861521; August 29, 1989. Suzuxi, K., and YOSHIOKA, H., Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1105, (5), 3265.
  • Significance of reactive oxygen species in distal flap necrosis and its salvage with liposomal SOD. SUZUKI, S., MIYACHI, Y., NIWA, Y., and Isstinci, N., Br. J. Plast. Surg., 1989, 42, (5), 559–564.
  • The organ distribution of liposome-encapsulated and free cobalt in rats. Liposomes decrease the cardiac uptake of the metal. SZENBEN1, J., GARCIA, R., ESKELSON, C. D., and CHVAPIL, M., Life Sci., 1989, 45, (8), 729–736.
  • Macrophage activation through phagocytosis of poly(L-lactic acid) microspheres containing an immunomodulatory agent. TABATA, Y., and NADA, Y Seitai Zairyo, 1989, 7, (2), 79–86.
  • Intra-arterial infusion port system for intermittent degradable starch microsphere chemoembolization and implantation method. TAKAYASU, Y., KOTAKE, M., YOKOYAMA, H., and TAKEHARA, M., Gan To Kagaku Ryoho, 1989, 16, (8, Part 2), 3075–3080.
  • In vitro targeting and cytotoxicity of adriamycin in liposomes bearing monoclonal antibody against rat or human gp125 cell proliferation-associated antigen. TANAKA, T., Suzum, S., MASUKO, T., and HASHIMOTO, Y., Jpn. J. Cancer Res., 1989, 80, (4), 380–386.
  • Permeability of oxidized phosphatidylcholine liposomes. TANFANI, F., and BERTOLI, E., Biochem. Biophys. Res. Commun., 1989, 163, (1), 241–246.
  • A model study of rhodopsin regeneration in visual cell. Photoisomerization of all-trans retinal in phosphatidylcholine vesicles. TANIE, H., OHBA, K., SAKURAI, M., INOUE, Y., and CHUJO, R., Bull. Chem. Soc. Jpn., 1989, 62, (8), 2589–2593.
  • The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. TAYLOR, K. M., TAYLOR, G., KELLAWAY, I. W., and STEVENS, J., Pharm. Res., 1989, 6, (7), 633–636.
  • The mechanism of quinone formation from carcinogenic benzo(a)pyrene mediated by lipid peroxidation in liposomal suspension. TERAO, J., and MATSUSHITA, S., Basic Life Sci., 1988, 49, 769–772.
  • Importance of physical association between antigen and liposomes in liposomes adjuvanticity. THERIEN, H. M., and SHAHUM, E., Immumol. Lett., 1989, 22, (4), 253–258.
  • Passive and carrier-mediated permeation of different nucleosides through the reconstituted nucleoside transporter. TSE, C. M., and YOUNG, J. D., Biochim. Biophys. Ada, 1989, 985, (3), 343–346.
  • Adsorption of anti-human C-reactive protein immunoglobulin on phospholipid-coated microcapsules. TSUCHIDA, T., KIMURA, S., and IMANISFII, Y., 3. Membr. Sc., 1989, 45, (1–2), 155–165.
  • Sumithion microcapsule. Tsuji, K., SHIN)°, G., ITon, T., TSUDA, S., and TAKAHASHI, N., Sumitomo Kagaku (Osaka), 1989, (1), 4–25.
  • Preparation and pharmacokinetic and pharmacodynamic evaluation of hydroxy propyl cellulose-ethyl cellulose microcapsules containing piretanide. TSUJIYAMA, T., Suzum, N., KAWATA, M., UCHIDA, T., and GOTO, S., J. Pharmacobiodyn., 1989, 12, (6), 311–323.
  • Liposomal gadolinium-DPTA: effect of encapsulation on enhancement of hepatoma model by MRI. UNGER, E. C., MACDOUGALL, P., Cum.'s, P., and TILcocK, C., Magn. Reson. Imaging, 1989, 7, (4), 417–423.
  • Phospholipid-dependence of plant UDP-glucose sterol beta-n-glucosyl transferase. IV. Reconstitution into small unilamellar vesicles. URY, A., BEN VENISTE, P., and BOUVIER, N. P., Plant Physiol., 1989, 91, (2), 567–573.
  • The liposome-mediated macrophage 'suicide' technique. VAN-Roo [JEN, N., J. Immunol. Methods, 1989, 124, (1), 1–6.
  • Effects of intracellular diphosphonates on cells of the mononuclear phagocyte system: in vivo effects of liposome-encapsulated diphosphonates on different macrophage subpopulations in the spleen. VAN-Rol:11)EN, N., and KORS, N., Calcif. Tissue Int., 1989,45, (3), 153–156.
  • Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a phosphorus-31 NMR study. VION-DURY, J., MASSON, S., DEVOISSELLE, J. M., SCIAKY, M., DESMOULIN, F., CONFORT-GOUNY, S., COUSTAUT, D., and COZZONE, P. J., J. Pharmacol. Exp. Ther., 1989, 250, (3), 1113–1118.
  • Sendai virus envelopes and erythrocyte ghosts as membrane vehicles for transport of the reactive oligonucleotide derivatives into the cells. VLASOV, V. V., IVANOVA, E. M., KRENDELEV, Yu. D., KUTYAVIN, I. V., OVANDER, M. M., RAIT, A. S., SVINARCHUK, F. P., and YAKUBOV, L. A., Biopolim. Kletka., 1989, 5, (4), 52–58.
  • Spin label and microcalorimetric studies of the interaction of DNA with unilamellar phosphatidylcholine liposomes. VOJCIKOVA, L., SVAJDLENKA, E., and BALGAVY, P., Gen. Physiol. Biophys., 1989, 8, (4), 399–406.
  • In vivo characterization of indomethacin magnetic polymethyl methacrylate nanoparticles. VYAS, S. P., and MALAIYA, A., J. Microencapszd., 1989, 6, (4), 493–499.
  • Antigen presentation by liposomes as model system for T-B cell interaction. WALDEN, P., Eur. J. Immunol., 1988, 18, (11), 1851–1854.
  • Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. WANG, C. Y., and HUANG, L., Biochemistry, 1989, 28, (24), 9508–9514.
  • Cell separation enhancement through microsphere mediated aggregation. WANG, H. Y., Abstr. Pap. Am. Chem. Soc., 1989, 198, MBTD 227.
  • Liposomes-drug carriers for retinally active drugs?. WEBER, U., MICHAELIS, L., KERN, W., and GOERZ, G., Fortschr. Ophthalmol., 1989, 86, (4), 383–386.
  • Liposomes as carriers for polypeptides. WEINER, A. L., Adv. Drug Delivery Rev., 1989, 3, (3), 307–342.
  • Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model. WEINER, N., WILLIAMS, N., BIRCH, G., RAMACHANDRAN, C., SHIPMAN, C. JR., and FLYNN, G., Antimicrob. Agents Chemother., 1989, 33, (8), 1217–1221.
  • Liposomes on the way to therapeutical use. WEISSIG, V., and LASCH, J., Wiss. Fortschr., 1989,39, (7), 178–180.
  • Reconstitution of glucose transport activity in liposomes to test proposed modulators of the transporter. WHEELER, T. J., Prog. Clin. Biol. Res., 1989, 292, 349–358.
  • Location and dynamics of alamethicin in unilamellar vesicles and thylakoids as model systems. A spin label study. WILLE, B., FRANZ, B., and JUNG, G., Biochim. Biophys. Acta, 1989, 986, (1), 47–60.
  • Magnetic microspheres (MMS) coupled to selective lectins: a new tool for large-scale extraction and purification of human pancreatic islets. WINOTO-MARBACH, S., LEYHAUSEN, G., SCHUENKE, M., DLRICHS, K., and MUELLER-RUCHHOLTZ, W., Transplant Proc., 1989, 21, (1, Book 3), 2628–2630.
  • Skin permeation of liposome incorporated hydrocortisone. WOHLRAB, W., LASCH, J., TAUBE, K. M., and WOZNIAK, K. D., Pharmazie, 1989, 44, (5), 333–335.
  • Antibody-directed liposomes as drug-delivery vehicles. WRIGHT, S., and HUANG, L., Adv. Drug Delivery Rev., 1989, 3, (3), 343–390.
  • Studies on the preparation of adenosine triphosphate (ATP) liposomes. Xu, G. X., and XIE, X. H., Yao Hsueh Hsueh Pao, 1989, 24, (2), 133–138.
  • Hydrolytic reaction catalyzed by poly-N-substituted glycines having imidazolyl groups in side chains in the presence of liposome. YAGI, Y., KIMURA, S., and ImmvIsm, Y., Biophys. Chem., 1989, 34, (1), 35–42.
  • Behavior and removal of impurity sulfate in sol-gel process for thorium dioxide and thorium-uranium dioxide microsphere fabrication. YAMAGISHI, S., and TAKAHASHI, Y., J. Nucl. Sci. Technol., 1989, 26, (10), 939–947.
  • Anticonvulsant effect of liposome-entrapped superoxide dismutase on kindled convulsion in rats. YOKOYAMA, H., MATSUMOTO, S., ISHIDA, S., MORI, N., and KUMASHIRO, H., Epilepsia, 1989, 30, (5), 647.
  • N-Acryloxysuccinimide-containing copolymeric microspheres for the immobilization of bimolecules. YOSHIDA, M., ASANO, M., YOKOTA, T., CHOSDU, R., and KUMAKURA, M., J. Polym. Sci., Part C: Polym. Lett., 1989, 27, (11), 437–442.
  • Synthesis and application of porous carrier for solid phase radioimmunoassay. YOU-YINGCAI, LIANG-XUN, TENG-XINLIAN, GUO-XIANQUAN, HOU-BINGZHANG, and YIN-BOYUAN., Gaodeng Xuexiao, Huaxue Xuebao, 1989, 10, (6), 638–641.
  • Inverted microcarriers: using microencapsulation to grow anchorage-dependent cells in suspension. YOUNG, D. V., DOBBELS, S., KING, L., DEER, F., and GILLIES, S. D., BioPharm., 1989, 2, (10), 34, 36, 38, 40–46.
  • A new bone marrow imaging agent: preparation of technetium-99m-polyphase liposomes and animal experiments. YU-BAOFA, ZHU-GUOHONG, TANG-JIN, WANG-HONG, and TIAN-ZHENJIE. Zhonghua Heyixue Zazhi, 1989, 9, (3), 167–168.
  • Treatment of N-nitrosobis(2-oxopropyl)amine-induce pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analog RC-160 microcapsules. ZALATNAI, A., and SCHALLY, A. V., Cancer Res., 1989, 49, (17), 4946.
  • Delivery of anticancer drugs. ZEE-CFIENG, R. K. Y., and CHENG, C. C., Methods Find. Exp. Clin. Pharmacol., 1989, 11, (7-8), 439–529.
  • Studies on the stability and some other important physical properties of polysaccharides polyphase liposome (PPL). Zou, Y .Y Su, D. S., HAN, G. C., and Gu, X. Q., Yao Hsueh Hsueh Pao, 1989, 24, (1), 58–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.